Gene Symbol | Gene ID | Gene Info |
---|---|---|
Irx6
|
ENSMUSG00000031738.8 | Iroquois homeobox 6 |
Irx2
|
ENSMUSG00000001504.9 | Iroquois homeobox 2 |
Irx3
|
ENSMUSG00000031734.11 | Iroquois related homeobox 3 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr13_72639713_72639891 | Irx2 | 7205 | 0.213200 | -0.39 | 4.4e-01 | Click! |
chr13_72640249_72640408 | Irx2 | 7731 | 0.211089 | -0.28 | 5.9e-01 | Click! |
chr8_91801944_91802115 | Irx3 | 38 | 0.634607 | -0.97 | 1.3e-03 | Click! |
chr8_91801411_91801577 | Irx3 | 421 | 0.605126 | -0.66 | 1.6e-01 | Click! |
chr8_91801689_91801867 | Irx3 | 137 | 0.779774 | 0.49 | 3.3e-01 | Click! |
chr8_92581152_92581303 | Irx6 | 93061 | 0.069361 | 0.44 | 3.8e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr3_97635501_97635936 | 8.06 |
Fmo5 |
flavin containing monooxygenase 5 |
6835 |
0.14 |
chr6_116064213_116064364 | 7.55 |
Tmcc1 |
transmembrane and coiled coil domains 1 |
6239 |
0.19 |
chr8_93179883_93180034 | 7.31 |
Ces1d |
carboxylesterase 1D |
4669 |
0.15 |
chr9_103217995_103218146 | 6.72 |
Trf |
transferrin |
1796 |
0.31 |
chr1_162891657_162891835 | 6.57 |
Fmo2 |
flavin containing monooxygenase 2 |
5231 |
0.19 |
chr19_44404842_44405075 | 6.49 |
Scd1 |
stearoyl-Coenzyme A desaturase 1 |
1732 |
0.29 |
chr19_44392649_44392816 | 5.95 |
Scd1 |
stearoyl-Coenzyme A desaturase 1 |
13958 |
0.14 |
chr3_138363372_138363558 | 5.80 |
Adh6-ps1 |
alcohol dehydrogenase 6 (class V), pseudogene 1 |
10656 |
0.12 |
chr3_138291566_138291979 | 5.73 |
Adh1 |
alcohol dehydrogenase 1 (class I) |
14121 |
0.11 |
chr3_149437041_149437628 | 5.68 |
Gm30382 |
predicted gene, 30382 |
7942 |
0.29 |
chr1_51760965_51761136 | 5.65 |
Myo1b |
myosin IB |
3420 |
0.25 |
chr8_22893346_22893646 | 5.59 |
Gm45555 |
predicted gene 45555 |
19907 |
0.14 |
chr16_30369037_30369274 | 5.55 |
Atp13a3 |
ATPase type 13A3 |
11912 |
0.2 |
chr4_19632141_19632303 | 5.52 |
Gm12353 |
predicted gene 12353 |
26771 |
0.17 |
chr15_54578033_54578470 | 5.51 |
Mal2 |
mal, T cell differentiation protein 2 |
7059 |
0.27 |
chr8_35211242_35211393 | 5.41 |
Gm34474 |
predicted gene, 34474 |
7321 |
0.15 |
chr15_35886635_35886786 | 5.21 |
Vps13b |
vacuolar protein sorting 13B |
14988 |
0.16 |
chr4_121163852_121164031 | 5.20 |
Rlf |
rearranged L-myc fusion sequence |
24593 |
0.11 |
chr16_93333790_93334136 | 5.19 |
1810053B23Rik |
RIKEN cDNA 1810053B23 gene |
19226 |
0.18 |
chr10_68103006_68103157 | 5.09 |
Arid5b |
AT rich interactive domain 5B (MRF1-like) |
33545 |
0.18 |
chr7_67696401_67696754 | 5.04 |
Gm44669 |
predicted gene 44669 |
15274 |
0.13 |
chr14_118948462_118948868 | 4.92 |
Dnajc3 |
DnaJ heat shock protein family (Hsp40) member C3 |
10689 |
0.16 |
chr4_40145230_40145427 | 4.91 |
Aco1 |
aconitase 1 |
2247 |
0.3 |
chr12_99858543_99858709 | 4.89 |
Efcab11 |
EF-hand calcium binding domain 11 |
24231 |
0.11 |
chr1_21260353_21260512 | 4.81 |
Gsta3 |
glutathione S-transferase, alpha 3 |
6911 |
0.11 |
chr8_36290613_36290918 | 4.66 |
Lonrf1 |
LON peptidase N-terminal domain and ring finger 1 |
41249 |
0.14 |
chr8_40882534_40882732 | 4.62 |
Slc7a2 |
solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 |
7685 |
0.16 |
chr3_129451172_129451350 | 4.53 |
Rpl7a-ps7 |
ribosomal protein L7A, pseudogene 7 |
10711 |
0.17 |
chr4_97933124_97933499 | 4.50 |
Nfia |
nuclear factor I/A |
22278 |
0.26 |
chr12_32678614_32678795 | 4.47 |
Gm47937 |
predicted gene, 47937 |
5410 |
0.25 |
chr2_31485846_31486386 | 4.41 |
Ass1 |
argininosuccinate synthetase 1 |
11656 |
0.18 |
chr14_101841763_101841965 | 4.39 |
Lmo7 |
LIM domain only 7 |
1045 |
0.64 |
chr17_70661451_70661755 | 4.30 |
5031415H12Rik |
RIKEN cDNA 5031415H12 gene |
93979 |
0.07 |
chr10_87883611_87883967 | 4.27 |
Igf1os |
insulin-like growth factor 1, opposite strand |
20408 |
0.18 |
chr8_93258234_93258385 | 4.26 |
Ces1f |
carboxylesterase 1F |
430 |
0.78 |
chr4_126764112_126764263 | 4.16 |
AU040320 |
expressed sequence AU040320 |
10361 |
0.13 |
chr11_20205712_20205888 | 4.11 |
Rab1a |
RAB1A, member RAS oncogene family |
4191 |
0.19 |
chr8_18724262_18724413 | 4.08 |
Angpt2 |
angiopoietin 2 |
17225 |
0.18 |
chr12_31294954_31295105 | 4.04 |
Lamb1 |
laminin B1 |
16854 |
0.13 |
chr1_191591538_191591710 | 4.03 |
Gm37349 |
predicted gene, 37349 |
6023 |
0.16 |
chr14_21177906_21178057 | 3.98 |
Adk |
adenosine kinase |
101829 |
0.07 |
chr18_36658751_36659052 | 3.92 |
Ankhd1 |
ankyrin repeat and KH domain containing 1 |
3391 |
0.11 |
chr16_46100990_46101141 | 3.92 |
Gm50487 |
predicted gene, 50487 |
14590 |
0.17 |
chr6_149225033_149225369 | 3.90 |
1700003I16Rik |
RIKEN cDNA 1700003I16 gene |
10016 |
0.16 |
chr13_112500358_112500528 | 3.89 |
Il6st |
interleukin 6 signal transducer |
25397 |
0.14 |
chr13_4514553_4514877 | 3.88 |
Akr1c20 |
aldo-keto reductase family 1, member C20 |
8598 |
0.19 |
chr4_129249637_129249797 | 3.86 |
C77080 |
expressed sequence C77080 |
1274 |
0.32 |
chr8_22877403_22877583 | 3.84 |
Gm45555 |
predicted gene 45555 |
3904 |
0.19 |
chr3_58454505_58454707 | 3.84 |
Tsc22d2 |
TSC22 domain family, member 2 |
37122 |
0.13 |
chr16_15889314_15889495 | 3.83 |
Cebpd |
CCAAT/enhancer binding protein (C/EBP), delta |
988 |
0.55 |
chr16_11884290_11884471 | 3.81 |
Gm9961 |
predicted gene 9961 |
16983 |
0.21 |
chr9_66697369_66697520 | 3.78 |
Car12 |
carbonic anhydrase 12 |
16242 |
0.19 |
chr7_44299592_44299763 | 3.76 |
Gm7238 |
predicted gene 7238 |
1210 |
0.18 |
chr2_79652088_79652307 | 3.75 |
Itprid2 |
ITPR interacting domain containing 2 |
13015 |
0.26 |
chr18_36665462_36665664 | 3.74 |
Eif4ebp3 |
eukaryotic translation initiation factor 4E binding protein 3 |
1503 |
0.2 |
chr16_37874612_37874787 | 3.73 |
Lrrc58 |
leucine rich repeat containing 58 |
6310 |
0.14 |
chr19_41581597_41581748 | 3.72 |
Lcor |
ligand dependent nuclear receptor corepressor |
698 |
0.68 |
chrX_140540020_140540246 | 3.71 |
Tsc22d3 |
TSC22 domain family, member 3 |
2535 |
0.29 |
chr14_62921769_62921931 | 3.70 |
Gm21021 |
predicted gene, 21021 |
51940 |
0.08 |
chr5_7958487_7958972 | 3.68 |
Gm30835 |
predicted gene, 30835 |
1617 |
0.29 |
chr5_24800499_24800655 | 3.68 |
Rheb |
Ras homolog enriched in brain |
13382 |
0.15 |
chr3_18138170_18138321 | 3.68 |
Gm23686 |
predicted gene, 23686 |
39380 |
0.16 |
chr10_87870357_87870520 | 3.66 |
Igf1os |
insulin-like growth factor 1, opposite strand |
7057 |
0.21 |
chr17_84646982_84647144 | 3.62 |
Dync2li1 |
dynein cytoplasmic 2 light intermediate chain 1 |
2212 |
0.22 |
chr14_21088077_21088228 | 3.62 |
Adk |
adenosine kinase |
12000 |
0.21 |
chr1_67104802_67105196 | 3.61 |
Cps1 |
carbamoyl-phosphate synthetase 1 |
18027 |
0.21 |
chr12_75470361_75470535 | 3.60 |
Gm47690 |
predicted gene, 47690 |
38297 |
0.16 |
chr15_62939365_62939695 | 3.59 |
Tsg101-ps |
tumor susceptibility gene 101, pseudogene |
41118 |
0.2 |
chr8_93166241_93166392 | 3.59 |
Ces1d |
carboxylesterase 1D |
3659 |
0.17 |
chr6_24046716_24047018 | 3.59 |
Slc13a1 |
solute carrier family 13 (sodium/sulfate symporters), member 1 |
61704 |
0.12 |
chr2_155929348_155929567 | 3.57 |
Uqcc1 |
ubiquinol-cytochrome c reductase complex assembly factor 1 |
561 |
0.64 |
chr4_140856184_140856335 | 3.55 |
Padi1 |
peptidyl arginine deiminase, type I |
10481 |
0.12 |
chr3_18157205_18157356 | 3.54 |
Gm23686 |
predicted gene, 23686 |
20345 |
0.21 |
chr8_105852398_105852549 | 3.54 |
Cenpt |
centromere protein T |
419 |
0.64 |
chr15_3461208_3461442 | 3.53 |
Ghr |
growth hormone receptor |
10319 |
0.29 |
chr2_135855339_135855516 | 3.51 |
Plcb4 |
phospholipase C, beta 4 |
32267 |
0.19 |
chr1_21249667_21249920 | 3.51 |
Gsta3 |
glutathione S-transferase, alpha 3 |
3728 |
0.14 |
chr7_90058476_90058627 | 3.48 |
Gm44861 |
predicted gene 44861 |
15854 |
0.12 |
chr19_40164076_40164449 | 3.42 |
Cyp2c70 |
cytochrome P450, family 2, subfamily c, polypeptide 70 |
23024 |
0.14 |
chr9_88439768_88439919 | 3.39 |
Snx14 |
sorting nexin 14 |
885 |
0.45 |
chr3_118663369_118663520 | 3.35 |
Dpyd |
dihydropyrimidine dehydrogenase |
101258 |
0.07 |
chr9_9107438_9107589 | 3.34 |
Gm16833 |
predicted gene, 16833 |
128775 |
0.05 |
chr4_135220987_135221138 | 3.32 |
Clic4 |
chloride intracellular channel 4 (mitochondrial) |
51752 |
0.09 |
chr13_48540722_48541023 | 3.31 |
Mirlet7a-1 |
microRNA let7a-1 |
2600 |
0.12 |
chr10_86690190_86690443 | 3.30 |
Gm15344 |
predicted gene 15344 |
2779 |
0.1 |
chr2_160803447_160803598 | 3.29 |
Gm11447 |
predicted gene 11447 |
42091 |
0.1 |
chr10_40511211_40511581 | 3.28 |
Gm18671 |
predicted gene, 18671 |
37496 |
0.14 |
chr3_157994042_157994282 | 3.27 |
Ankrd13c |
ankyrin repeat domain 13c |
51 |
0.96 |
chr3_69664425_69664589 | 3.22 |
Gm37380 |
predicted gene, 37380 |
2741 |
0.24 |
chr15_31250860_31251157 | 3.21 |
Dap |
death-associated protein |
17328 |
0.15 |
chr4_59568064_59568258 | 3.21 |
Hsdl2 |
hydroxysteroid dehydrogenase like 2 |
13402 |
0.15 |
chr10_20473895_20474094 | 3.20 |
Pde7b |
phosphodiesterase 7B |
27103 |
0.17 |
chr4_61962021_61962172 | 3.19 |
Mup-ps19 |
major urinary protein, pseudogene 19 |
2185 |
0.28 |
chr14_114073755_114073939 | 3.18 |
Gm18369 |
predicted gene, 18369 |
98596 |
0.09 |
chr10_24912717_24913171 | 3.17 |
Mir6905 |
microRNA 6905 |
2280 |
0.2 |
chr1_67214969_67215120 | 3.17 |
Gm15668 |
predicted gene 15668 |
34156 |
0.17 |
chr7_102061119_102061270 | 3.17 |
Rnf121 |
ring finger protein 121 |
718 |
0.47 |
chr4_94614907_94615058 | 3.16 |
Ift74 |
intraflagellar transport 74 |
491 |
0.74 |
chr2_126950478_126950775 | 3.16 |
Sppl2a |
signal peptide peptidase like 2A |
17391 |
0.16 |
chr19_32807644_32807795 | 3.13 |
Pten |
phosphatase and tensin homolog |
3506 |
0.32 |
chr8_93077902_93078174 | 3.13 |
Ces1b |
carboxylesterase 1B |
1979 |
0.28 |
chr6_72155996_72156358 | 3.12 |
Gm38832 |
predicted gene, 38832 |
6672 |
0.15 |
chr10_89450844_89451017 | 3.10 |
Gas2l3 |
growth arrest-specific 2 like 3 |
6963 |
0.25 |
chr14_101854215_101854466 | 3.09 |
Lmo7 |
LIM domain only 7 |
13521 |
0.26 |
chr1_67169083_67169234 | 3.08 |
Cps1 |
carbamoyl-phosphate synthetase 1 |
46132 |
0.15 |
chr12_16618602_16618763 | 3.06 |
Lpin1 |
lipin 1 |
7716 |
0.2 |
chr16_24877282_24877474 | 3.06 |
Gm22672 |
predicted gene, 22672 |
6795 |
0.24 |
chr1_162837848_162837999 | 3.04 |
Fmo1 |
flavin containing monooxygenase 1 |
3251 |
0.23 |
chr8_54925357_54925725 | 3.02 |
Gpm6a |
glycoprotein m6a |
29302 |
0.13 |
chr15_12439573_12439745 | 3.02 |
Pdzd2 |
PDZ domain containing 2 |
27279 |
0.19 |
chr1_105988553_105988761 | 3.01 |
Gm7160 |
predicted gene 7160 |
1595 |
0.28 |
chr2_53182959_53183110 | 3.00 |
Prpf40a |
pre-mRNA processing factor 40A |
7066 |
0.24 |
chr10_87032560_87032752 | 2.99 |
Stab2 |
stabilin 2 |
24631 |
0.14 |
chr15_4752117_4752269 | 2.98 |
C6 |
complement component 6 |
13752 |
0.24 |
chr11_16816779_16816940 | 2.96 |
Egfros |
epidermal growth factor receptor, opposite strand |
13843 |
0.21 |
chr6_28031509_28031660 | 2.95 |
Grm8 |
glutamate receptor, metabotropic 8 |
94541 |
0.08 |
chr4_154142001_154142154 | 2.94 |
Wrap73 |
WD repeat containing, antisense to Trp73 |
295 |
0.82 |
chr2_50285067_50285218 | 2.93 |
Mmadhc |
methylmalonic aciduria (cobalamin deficiency) cblD type, with homocystinuria |
4057 |
0.26 |
chr19_12444451_12444657 | 2.93 |
Mpeg1 |
macrophage expressed gene 1 |
16225 |
0.1 |
chr6_116044893_116045061 | 2.93 |
Tmcc1 |
transmembrane and coiled coil domains 1 |
11978 |
0.17 |
chr11_87668675_87668848 | 2.92 |
Rnf43 |
ring finger protein 43 |
4212 |
0.14 |
chr13_51102743_51102914 | 2.92 |
Spin1 |
spindlin 1 |
1948 |
0.39 |
chr11_77363992_77364232 | 2.92 |
Ssh2 |
slingshot protein phosphatase 2 |
15824 |
0.18 |
chr11_16850518_16850669 | 2.91 |
Egfros |
epidermal growth factor receptor, opposite strand |
19891 |
0.18 |
chr11_70501874_70502034 | 2.90 |
Tm4sf5 |
transmembrane 4 superfamily member 5 |
3290 |
0.09 |
chr11_29821731_29821882 | 2.90 |
Eml6 |
echinoderm microtubule associated protein like 6 |
144 |
0.95 |
chr8_46750876_46751065 | 2.89 |
Irf2 |
interferon regulatory factor 2 |
10704 |
0.14 |
chr3_133723322_133723475 | 2.89 |
Gm40153 |
predicted gene, 40153 |
60007 |
0.11 |
chr9_90111740_90111972 | 2.88 |
Morf4l1 |
mortality factor 4 like 1 |
2433 |
0.23 |
chr2_71875061_71875212 | 2.87 |
Pdk1 |
pyruvate dehydrogenase kinase, isoenzyme 1 |
57 |
0.98 |
chr11_20229877_20230091 | 2.87 |
Cep68 |
centrosomal protein 68 |
19399 |
0.15 |
chr1_79822993_79823175 | 2.86 |
Serpine2 |
serine (or cysteine) peptidase inhibitor, clade E, member 2 |
1762 |
0.36 |
chr12_100421631_100422293 | 2.86 |
Gm48381 |
predicted gene, 48381 |
22698 |
0.15 |
chr3_58520131_58520481 | 2.86 |
Eif2a |
eukaryotic translation initiation factor 2A |
5515 |
0.16 |
chr5_66037277_66037428 | 2.84 |
Rbm47 |
RNA binding motif protein 47 |
17200 |
0.11 |
chr11_16861451_16861695 | 2.83 |
Egfr |
epidermal growth factor receptor |
16577 |
0.19 |
chr10_98948366_98948523 | 2.82 |
Atp2b1 |
ATPase, Ca++ transporting, plasma membrane 1 |
32972 |
0.19 |
chr7_26106322_26106473 | 2.82 |
Gm29920 |
predicted gene, 29920 |
6081 |
0.15 |
chr6_72350688_72350839 | 2.79 |
Gm45051 |
predicted gene 45051 |
2305 |
0.14 |
chr19_37078496_37078665 | 2.78 |
Gm22714 |
predicted gene, 22714 |
70582 |
0.09 |
chr7_114361745_114361949 | 2.78 |
4933406I18Rik |
RIKEN cDNA 4933406I18 gene |
53174 |
0.12 |
chr2_90916887_90917038 | 2.78 |
Ptpmt1 |
protein tyrosine phosphatase, mitochondrial 1 |
634 |
0.38 |
chr1_161244723_161244874 | 2.77 |
Prdx6 |
peroxiredoxin 6 |
5756 |
0.18 |
chr3_138233542_138233745 | 2.77 |
Adh7 |
alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide |
5592 |
0.13 |
chr7_137621172_137621473 | 2.77 |
Gm45683 |
predicted gene 45683 |
27767 |
0.21 |
chr5_104437037_104437216 | 2.75 |
Spp1 |
secreted phosphoprotein 1 |
934 |
0.48 |
chr4_109106304_109106455 | 2.75 |
Osbpl9 |
oxysterol binding protein-like 9 |
1652 |
0.4 |
chr2_13522226_13522421 | 2.75 |
Trdmt1 |
tRNA aspartic acid methyltransferase 1 |
22327 |
0.19 |
chr6_59446176_59446340 | 2.74 |
Gprin3 |
GPRIN family member 3 |
19964 |
0.28 |
chr9_90262491_90262655 | 2.73 |
Tbc1d2b |
TBC1 domain family, member 2B |
6646 |
0.18 |
chr7_87371791_87371944 | 2.73 |
Tyr |
tyrosinase |
121525 |
0.05 |
chr19_46609384_46609535 | 2.73 |
Wbp1l |
WW domain binding protein 1 like |
10335 |
0.13 |
chr3_14800230_14800479 | 2.72 |
Gm16399 |
predicted pseudogene 16399 |
2220 |
0.29 |
chr1_21259850_21260251 | 2.72 |
Gsta3 |
glutathione S-transferase, alpha 3 |
6529 |
0.11 |
chr8_35390018_35390398 | 2.71 |
Ppp1r3b |
protein phosphatase 1, regulatory subunit 3B |
13548 |
0.15 |
chr1_13322152_13322303 | 2.71 |
Gm23169 |
predicted gene, 23169 |
12382 |
0.11 |
chr7_63916741_63916912 | 2.70 |
E030018B13Rik |
RIKEN cDNA E030018B13 gene |
31 |
0.97 |
chr13_113052500_113052836 | 2.70 |
Gpx8 |
glutathione peroxidase 8 (putative) |
6258 |
0.09 |
chr19_8400709_8400872 | 2.70 |
Slc22a30 |
solute carrier family 22, member 30 |
4270 |
0.24 |
chr15_59004950_59005135 | 2.70 |
4930544F09Rik |
RIKEN cDNA 4930544F09 gene |
20906 |
0.16 |
chr1_21259122_21259550 | 2.69 |
Gsta3 |
glutathione S-transferase, alpha 3 |
5815 |
0.12 |
chr8_35087443_35087746 | 2.67 |
Gm34419 |
predicted gene, 34419 |
6951 |
0.18 |
chr3_135146834_135146985 | 2.67 |
Gm24048 |
predicted gene, 24048 |
499 |
0.77 |
chr6_124455872_124456023 | 2.67 |
Clstn3 |
calsyntenin 3 |
1938 |
0.2 |
chr6_21805742_21806007 | 2.66 |
Tspan12 |
tetraspanin 12 |
45954 |
0.14 |
chr2_166007450_166007601 | 2.65 |
Ncoa3 |
nuclear receptor coactivator 3 |
14888 |
0.13 |
chr2_165964170_165964595 | 2.65 |
Gm11462 |
predicted gene 11462 |
4593 |
0.15 |
chr13_75842276_75842441 | 2.65 |
Glrx |
glutaredoxin |
2282 |
0.24 |
chr13_112469834_112470052 | 2.64 |
Il6st |
interleukin 6 signal transducer |
2350 |
0.26 |
chr13_54430445_54430756 | 2.63 |
Gm16248 |
predicted gene 16248 |
31266 |
0.12 |
chr14_21101960_21102164 | 2.63 |
Adk |
adenosine kinase |
25910 |
0.19 |
chr1_22135980_22136173 | 2.63 |
Gm28239 |
predicted gene 28239 |
101773 |
0.07 |
chr7_63929445_63929632 | 2.62 |
Klf13 |
Kruppel-like factor 13 |
4668 |
0.15 |
chr1_67224202_67224476 | 2.62 |
Gm15668 |
predicted gene 15668 |
24861 |
0.19 |
chr8_114140204_114140427 | 2.62 |
Nudt7 |
nudix (nucleoside diphosphate linked moiety X)-type motif 7 |
6673 |
0.29 |
chr11_50312964_50313201 | 2.60 |
Canx |
calnexin |
12092 |
0.12 |
chr4_53099364_53099515 | 2.59 |
Abca1 |
ATP-binding cassette, sub-family A (ABC1), member 1 |
58513 |
0.11 |
chr10_87901489_87901918 | 2.59 |
Igf1os |
insulin-like growth factor 1, opposite strand |
38322 |
0.14 |
chr5_96135757_96135924 | 2.59 |
Cnot6l |
CCR4-NOT transcription complex, subunit 6-like |
6812 |
0.24 |
chr1_161240782_161240933 | 2.59 |
Prdx6 |
peroxiredoxin 6 |
9697 |
0.16 |
chr3_151893074_151893376 | 2.59 |
Gm43617 |
predicted gene 43617 |
5922 |
0.18 |
chr4_40159746_40159897 | 2.58 |
Aco1 |
aconitase 1 |
3898 |
0.23 |
chr4_96661838_96661989 | 2.58 |
Cyp2j5 |
cytochrome P450, family 2, subfamily j, polypeptide 5 |
2241 |
0.39 |
chr19_40090346_40090724 | 2.57 |
Cyp2c50 |
cytochrome P450, family 2, subfamily c, polypeptide 50 |
800 |
0.64 |
chr14_70763141_70763352 | 2.57 |
Dok2 |
docking protein 2 |
2790 |
0.23 |
chr2_58784716_58784992 | 2.57 |
Upp2 |
uridine phosphorylase 2 |
19529 |
0.19 |
chr5_130090353_130090504 | 2.56 |
Tpst1 |
protein-tyrosine sulfotransferase 1 |
3161 |
0.18 |
chr6_28634871_28635022 | 2.55 |
Gm37978 |
predicted gene, 37978 |
66874 |
0.09 |
chr4_129322034_129322197 | 2.55 |
Rbbp4 |
retinoblastoma binding protein 4, chromatin remodeling factor |
12529 |
0.11 |
chr7_123462508_123463004 | 2.55 |
Aqp8 |
aquaporin 8 |
444 |
0.83 |
chr1_151689614_151690051 | 2.55 |
Fam129a |
family with sequence similarity 129, member A |
12665 |
0.21 |
chr3_11037493_11037644 | 2.55 |
Gm37832 |
predicted gene, 37832 |
6790 |
0.24 |
chr1_192082357_192082528 | 2.55 |
Gstp-ps |
glutathione S-transferase, pi, pseudogene |
7992 |
0.13 |
chr4_134837028_134837206 | 2.54 |
Maco1 |
macoilin 1 |
16032 |
0.17 |
chr8_46515572_46515854 | 2.54 |
Acsl1 |
acyl-CoA synthetase long-chain family member 1 |
11073 |
0.16 |
chr13_52771924_52772129 | 2.54 |
BB123696 |
expressed sequence BB123696 |
14821 |
0.27 |
chr4_76289707_76290307 | 2.54 |
Ptprd |
protein tyrosine phosphatase, receptor type, D |
35236 |
0.22 |
chr9_80672315_80672507 | 2.53 |
Gm39380 |
predicted gene, 39380 |
37584 |
0.19 |
chr3_149181265_149181842 | 2.52 |
Gm42647 |
predicted gene 42647 |
28718 |
0.19 |
chr13_93622998_93623302 | 2.52 |
Gm15622 |
predicted gene 15622 |
2232 |
0.26 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.9 | 8.8 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
2.0 | 6.1 | GO:0006068 | ethanol catabolic process(GO:0006068) |
1.7 | 10.0 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
1.4 | 5.5 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
1.3 | 4.0 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
1.3 | 2.5 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
1.2 | 5.0 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
1.1 | 3.3 | GO:2000259 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
1.1 | 7.4 | GO:0070995 | NADPH oxidation(GO:0070995) |
1.0 | 2.1 | GO:2000809 | positive regulation of synaptic vesicle clustering(GO:2000809) |
1.0 | 4.0 | GO:0046449 | creatinine metabolic process(GO:0046449) cellular lactam metabolic process(GO:0072338) |
1.0 | 2.9 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
0.9 | 2.8 | GO:0060523 | prostate epithelial cord elongation(GO:0060523) |
0.9 | 1.8 | GO:2000909 | regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
0.9 | 2.6 | GO:0032439 | endosome localization(GO:0032439) |
0.9 | 6.0 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.9 | 5.1 | GO:0072602 | interleukin-4 secretion(GO:0072602) |
0.8 | 2.4 | GO:0070447 | positive regulation of oligodendrocyte progenitor proliferation(GO:0070447) |
0.7 | 2.2 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
0.7 | 2.2 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
0.7 | 2.0 | GO:0006562 | proline catabolic process(GO:0006562) |
0.7 | 4.7 | GO:0035437 | maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.7 | 0.7 | GO:0006067 | ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
0.6 | 1.9 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
0.6 | 1.3 | GO:1904339 | negative regulation of dopaminergic neuron differentiation(GO:1904339) |
0.6 | 1.9 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
0.6 | 1.9 | GO:0070103 | regulation of interleukin-6-mediated signaling pathway(GO:0070103) |
0.6 | 1.9 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.6 | 3.7 | GO:0042737 | drug catabolic process(GO:0042737) |
0.6 | 1.8 | GO:0019287 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.6 | 1.8 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.6 | 1.7 | GO:0051594 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.6 | 2.9 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.6 | 2.8 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.5 | 2.7 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.5 | 1.6 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.5 | 1.5 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
0.5 | 1.5 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.5 | 3.0 | GO:0021960 | anterior commissure morphogenesis(GO:0021960) |
0.5 | 2.5 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.5 | 4.0 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.5 | 2.0 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
0.5 | 1.4 | GO:0008050 | female courtship behavior(GO:0008050) |
0.5 | 1.4 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.5 | 1.4 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.5 | 3.6 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.4 | 2.2 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.4 | 1.7 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.4 | 0.4 | GO:0044828 | negative regulation by host of viral process(GO:0044793) negative regulation by host of viral genome replication(GO:0044828) |
0.4 | 1.3 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.4 | 0.8 | GO:1904016 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.4 | 2.5 | GO:0055091 | phospholipid homeostasis(GO:0055091) |
0.4 | 0.8 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
0.4 | 1.6 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.4 | 1.6 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.4 | 0.4 | GO:0031587 | positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
0.4 | 2.9 | GO:0017144 | drug metabolic process(GO:0017144) |
0.4 | 2.4 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.4 | 1.2 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
0.4 | 0.8 | GO:0036022 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
0.4 | 1.2 | GO:0048208 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
0.4 | 1.2 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.4 | 0.8 | GO:0072361 | regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) |
0.4 | 1.9 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.4 | 0.8 | GO:2000587 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.4 | 2.3 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.4 | 0.8 | GO:1904023 | regulation of fermentation(GO:0043465) regulation of NAD metabolic process(GO:1902688) regulation of glucose catabolic process to lactate via pyruvate(GO:1904023) |
0.4 | 1.1 | GO:0006210 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.4 | 1.9 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.4 | 0.4 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
0.4 | 1.5 | GO:1901300 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
0.4 | 0.7 | GO:0090114 | COPII-coated vesicle budding(GO:0090114) |
0.4 | 2.5 | GO:1900103 | positive regulation of endoplasmic reticulum unfolded protein response(GO:1900103) |
0.4 | 1.1 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
0.4 | 1.1 | GO:0042628 | mating plug formation(GO:0042628) post-mating behavior(GO:0045297) |
0.3 | 1.0 | GO:1900377 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.3 | 1.4 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
0.3 | 0.7 | GO:0010956 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) |
0.3 | 0.7 | GO:0086023 | adrenergic receptor signaling pathway involved in heart process(GO:0086023) |
0.3 | 2.7 | GO:0036315 | cellular response to sterol(GO:0036315) |
0.3 | 1.0 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.3 | 0.7 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
0.3 | 3.0 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.3 | 0.7 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.3 | 1.0 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.3 | 4.0 | GO:0071498 | cellular response to fluid shear stress(GO:0071498) |
0.3 | 0.7 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.3 | 1.3 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
0.3 | 0.6 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.3 | 0.6 | GO:0007403 | glial cell fate determination(GO:0007403) |
0.3 | 1.3 | GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) |
0.3 | 0.6 | GO:0070672 | response to interleukin-15(GO:0070672) |
0.3 | 1.3 | GO:0003383 | apical constriction(GO:0003383) |
0.3 | 1.3 | GO:2000370 | positive regulation of clathrin-mediated endocytosis(GO:2000370) |
0.3 | 2.8 | GO:0052697 | xenobiotic glucuronidation(GO:0052697) |
0.3 | 0.9 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
0.3 | 0.9 | GO:0001927 | exocyst assembly(GO:0001927) |
0.3 | 0.9 | GO:0030397 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
0.3 | 0.9 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
0.3 | 1.5 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.3 | 4.1 | GO:0003334 | keratinocyte development(GO:0003334) |
0.3 | 1.8 | GO:0061042 | vascular wound healing(GO:0061042) |
0.3 | 1.4 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.3 | 1.1 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.3 | 0.6 | GO:0010963 | regulation of L-arginine import(GO:0010963) |
0.3 | 0.8 | GO:0035513 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
0.3 | 0.3 | GO:0038095 | Fc-epsilon receptor signaling pathway(GO:0038095) |
0.3 | 0.6 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.3 | 0.8 | GO:0098700 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.3 | 0.8 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
0.3 | 0.8 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
0.3 | 1.6 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.3 | 1.4 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.3 | 0.5 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
0.3 | 0.8 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
0.3 | 0.3 | GO:0042908 | xenobiotic transport(GO:0042908) |
0.3 | 0.5 | GO:0002155 | regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
0.3 | 0.8 | GO:0002370 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.3 | 0.8 | GO:1902966 | regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
0.3 | 2.9 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
0.3 | 2.9 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.3 | 1.5 | GO:0000012 | single strand break repair(GO:0000012) |
0.3 | 0.5 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
0.3 | 1.5 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
0.3 | 1.0 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.3 | 1.5 | GO:0044598 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.3 | 0.8 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.3 | 1.0 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
0.2 | 1.7 | GO:0045908 | negative regulation of vasodilation(GO:0045908) |
0.2 | 1.0 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.2 | 1.7 | GO:0006655 | phosphatidylglycerol biosynthetic process(GO:0006655) |
0.2 | 0.2 | GO:0060916 | mesenchymal cell proliferation involved in lung development(GO:0060916) |
0.2 | 2.2 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.2 | 0.5 | GO:0033239 | negative regulation of cellular amine metabolic process(GO:0033239) |
0.2 | 2.4 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.2 | 0.7 | GO:1901740 | negative regulation of myoblast fusion(GO:1901740) |
0.2 | 0.7 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.2 | 0.5 | GO:0070874 | negative regulation of glycogen metabolic process(GO:0070874) |
0.2 | 1.0 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.2 | 0.5 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
0.2 | 0.5 | GO:0035973 | aggrephagy(GO:0035973) |
0.2 | 7.8 | GO:0060325 | face morphogenesis(GO:0060325) |
0.2 | 0.7 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.2 | 0.2 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
0.2 | 0.7 | GO:0035983 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
0.2 | 0.5 | GO:0034633 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
0.2 | 0.7 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.2 | 0.5 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
0.2 | 1.2 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.2 | 1.6 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.2 | 0.4 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
0.2 | 0.7 | GO:1904430 | negative regulation of t-circle formation(GO:1904430) |
0.2 | 1.1 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.2 | 0.4 | GO:1902915 | negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
0.2 | 1.1 | GO:0018101 | protein citrullination(GO:0018101) |
0.2 | 0.7 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.2 | 0.4 | GO:0043366 | beta selection(GO:0043366) |
0.2 | 1.1 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.2 | 1.3 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.2 | 0.7 | GO:0006203 | dGTP catabolic process(GO:0006203) |
0.2 | 0.7 | GO:1904252 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
0.2 | 1.5 | GO:1901339 | regulation of store-operated calcium channel activity(GO:1901339) |
0.2 | 0.9 | GO:0018211 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.2 | 3.5 | GO:0099514 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.2 | 0.4 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.2 | 0.9 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.2 | 0.2 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
0.2 | 0.4 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.2 | 0.4 | GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
0.2 | 1.0 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.2 | 0.4 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
0.2 | 0.6 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.2 | 0.8 | GO:0097461 | ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) |
0.2 | 0.6 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) |
0.2 | 0.8 | GO:0051136 | regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
0.2 | 0.6 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.2 | 0.6 | GO:0046618 | drug export(GO:0046618) |
0.2 | 0.6 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.2 | 0.6 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.2 | 0.4 | GO:0035459 | cargo loading into vesicle(GO:0035459) |
0.2 | 0.6 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.2 | 0.2 | GO:0061419 | positive regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061419) |
0.2 | 0.8 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
0.2 | 0.6 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
0.2 | 0.6 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.2 | 1.2 | GO:0015074 | DNA integration(GO:0015074) |
0.2 | 0.6 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
0.2 | 0.6 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.2 | 0.6 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.2 | 0.9 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
0.2 | 0.6 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.2 | 0.7 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
0.2 | 0.9 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.2 | 1.3 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.2 | 0.6 | GO:0006227 | dUDP biosynthetic process(GO:0006227) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dUDP metabolic process(GO:0046077) |
0.2 | 0.2 | GO:0046490 | isopentenyl diphosphate metabolic process(GO:0046490) |
0.2 | 0.4 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.2 | 0.6 | GO:0045415 | negative regulation of interleukin-8 biosynthetic process(GO:0045415) |
0.2 | 0.7 | GO:0051697 | protein delipidation(GO:0051697) |
0.2 | 0.2 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.2 | 0.2 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
0.2 | 0.4 | GO:2000409 | positive regulation of T cell extravasation(GO:2000409) |
0.2 | 0.4 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.2 | 0.5 | GO:0046684 | response to pyrethroid(GO:0046684) |
0.2 | 0.5 | GO:0015889 | cobalamin transport(GO:0015889) |
0.2 | 0.4 | GO:0010288 | response to lead ion(GO:0010288) |
0.2 | 0.5 | GO:1903660 | regulation of complement-dependent cytotoxicity(GO:1903659) negative regulation of complement-dependent cytotoxicity(GO:1903660) |
0.2 | 0.5 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
0.2 | 0.9 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.2 | 2.8 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.2 | 0.2 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.2 | 1.9 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.2 | 0.7 | GO:0090188 | negative regulation of pancreatic juice secretion(GO:0090188) |
0.2 | 0.2 | GO:0021564 | vagus nerve development(GO:0021564) |
0.2 | 0.3 | GO:0002071 | glandular epithelial cell maturation(GO:0002071) |
0.2 | 2.6 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.2 | 1.0 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.2 | 0.7 | GO:0021873 | forebrain neuroblast division(GO:0021873) |
0.2 | 0.7 | GO:0035356 | cellular triglyceride homeostasis(GO:0035356) |
0.2 | 0.3 | GO:0021553 | olfactory nerve development(GO:0021553) |
0.2 | 0.5 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.2 | 0.7 | GO:1904382 | protein deglycosylation involved in glycoprotein catabolic process(GO:0035977) protein demannosylation(GO:0036507) protein alpha-1,2-demannosylation(GO:0036508) mannose trimming involved in glycoprotein ERAD pathway(GO:1904382) |
0.2 | 0.8 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.2 | 1.5 | GO:0045176 | apical protein localization(GO:0045176) |
0.2 | 0.5 | GO:0015817 | histidine transport(GO:0015817) |
0.2 | 0.5 | GO:0071866 | regulation of apoptotic process in bone marrow(GO:0071865) negative regulation of apoptotic process in bone marrow(GO:0071866) |
0.2 | 1.0 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.2 | 0.6 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.2 | 0.6 | GO:0035627 | ceramide transport(GO:0035627) |
0.2 | 0.6 | GO:1902414 | protein localization to cell junction(GO:1902414) |
0.2 | 1.4 | GO:0055064 | chloride ion homeostasis(GO:0055064) |
0.2 | 1.6 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.2 | 0.3 | GO:0071276 | cellular response to cadmium ion(GO:0071276) |
0.2 | 0.6 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.2 | 0.2 | GO:0042525 | tyrosine phosphorylation of Stat6 protein(GO:0042505) regulation of tyrosine phosphorylation of Stat6 protein(GO:0042525) |
0.2 | 1.6 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
0.2 | 0.5 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
0.2 | 0.3 | GO:0032377 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.2 | 0.9 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.2 | 0.6 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.2 | 0.2 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.2 | 0.6 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.2 | 0.5 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.2 | 4.2 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.2 | 0.2 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
0.1 | 0.7 | GO:0071684 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.1 | 0.6 | GO:0071674 | mononuclear cell migration(GO:0071674) |
0.1 | 1.6 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.1 | 0.3 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.1 | 0.1 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.1 | 0.4 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.1 | 0.6 | GO:0015808 | L-alanine transport(GO:0015808) |
0.1 | 1.0 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.1 | 0.1 | GO:0061198 | fungiform papilla formation(GO:0061198) |
0.1 | 0.6 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
0.1 | 1.2 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.1 | 1.4 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.1 | 1.1 | GO:0060900 | embryonic camera-type eye formation(GO:0060900) |
0.1 | 0.6 | GO:0035791 | platelet-derived growth factor receptor-beta signaling pathway(GO:0035791) |
0.1 | 0.1 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.1 | 0.6 | GO:0046218 | tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) |
0.1 | 2.0 | GO:0045056 | transcytosis(GO:0045056) |
0.1 | 0.3 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.1 | 0.1 | GO:0043691 | reverse cholesterol transport(GO:0043691) |
0.1 | 0.4 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.1 | 0.6 | GO:0019532 | oxalate transport(GO:0019532) |
0.1 | 0.4 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.1 | 0.5 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.1 | 0.1 | GO:0061687 | detoxification of inorganic compound(GO:0061687) |
0.1 | 0.4 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.1 | 0.3 | GO:1903347 | negative regulation of bicellular tight junction assembly(GO:1903347) |
0.1 | 0.7 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.1 | 0.4 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.1 | 0.3 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.1 | 0.1 | GO:0065001 | specification of axis polarity(GO:0065001) |
0.1 | 1.1 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.1 | 0.4 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.1 | 0.3 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
0.1 | 0.8 | GO:0071267 | amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) |
0.1 | 0.4 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.1 | 0.5 | GO:0061724 | lipophagy(GO:0061724) |
0.1 | 1.3 | GO:0071071 | regulation of phospholipid biosynthetic process(GO:0071071) |
0.1 | 0.4 | GO:0046984 | regulation of hemoglobin biosynthetic process(GO:0046984) |
0.1 | 0.5 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.1 | 0.3 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.1 | 1.0 | GO:0060213 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
0.1 | 0.3 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
0.1 | 0.4 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.1 | 0.4 | GO:0070842 | aggresome assembly(GO:0070842) |
0.1 | 0.9 | GO:1904152 | regulation of retrograde protein transport, ER to cytosol(GO:1904152) |
0.1 | 2.0 | GO:0097352 | autophagosome maturation(GO:0097352) vacuole fusion(GO:0097576) |
0.1 | 0.5 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.1 | 0.5 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.1 | 0.8 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.1 | 0.4 | GO:2000224 | regulation of testosterone biosynthetic process(GO:2000224) |
0.1 | 1.0 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.1 | 0.6 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.1 | 1.0 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.1 | 0.4 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.1 | 0.5 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
0.1 | 0.6 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.1 | 0.4 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.1 | 0.4 | GO:0060744 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
0.1 | 0.2 | GO:0002930 | trabecular meshwork development(GO:0002930) |
0.1 | 0.4 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.1 | 0.4 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.1 | 0.5 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
0.1 | 0.2 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.1 | 2.1 | GO:0071539 | protein localization to centrosome(GO:0071539) |
0.1 | 0.4 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.1 | 0.8 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.1 | 0.5 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
0.1 | 0.2 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
0.1 | 0.9 | GO:0051451 | myoblast migration(GO:0051451) |
0.1 | 0.5 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.1 | 0.8 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
0.1 | 0.1 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
0.1 | 0.2 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
0.1 | 1.0 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.1 | 0.3 | GO:1902775 | mitochondrial ribosome assembly(GO:0061668) mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.1 | 0.1 | GO:0060921 | sinoatrial node cell differentiation(GO:0060921) cardiac pacemaker cell development(GO:0060926) sinoatrial node cell development(GO:0060931) |
0.1 | 0.5 | GO:0048669 | collateral sprouting in absence of injury(GO:0048669) |
0.1 | 1.0 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.1 | 0.2 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.1 | 4.2 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
0.1 | 0.1 | GO:0032349 | positive regulation of aldosterone metabolic process(GO:0032346) positive regulation of aldosterone biosynthetic process(GO:0032349) |
0.1 | 2.2 | GO:0006783 | heme biosynthetic process(GO:0006783) |
0.1 | 1.8 | GO:0033005 | positive regulation of mast cell activation(GO:0033005) |
0.1 | 0.2 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.1 | 0.4 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.1 | 0.1 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.1 | 0.2 | GO:0031296 | B cell costimulation(GO:0031296) |
0.1 | 0.8 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.1 | 0.8 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.1 | 0.6 | GO:0015879 | carnitine transport(GO:0015879) |
0.1 | 0.6 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
0.1 | 0.1 | GO:2001225 | regulation of chloride transport(GO:2001225) |
0.1 | 0.8 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.1 | 0.4 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.1 | 0.2 | GO:0061072 | iris morphogenesis(GO:0061072) |
0.1 | 1.0 | GO:0009435 | NAD biosynthetic process(GO:0009435) |
0.1 | 0.1 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.1 | 0.1 | GO:0015677 | copper ion import(GO:0015677) |
0.1 | 0.3 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.1 | 0.1 | GO:0014732 | skeletal muscle atrophy(GO:0014732) |
0.1 | 0.3 | GO:0042996 | regulation of Golgi to plasma membrane protein transport(GO:0042996) |
0.1 | 0.1 | GO:0032278 | positive regulation of gonadotropin secretion(GO:0032278) |
0.1 | 1.6 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.1 | 0.4 | GO:0072201 | negative regulation of mesenchymal cell proliferation(GO:0072201) |
0.1 | 0.3 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
0.1 | 0.3 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.1 | 0.5 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
0.1 | 0.5 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) telomere maintenance in response to DNA damage(GO:0043247) |
0.1 | 0.5 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
0.1 | 0.8 | GO:0031441 | negative regulation of mRNA 3'-end processing(GO:0031441) |
0.1 | 0.7 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.1 | 0.5 | GO:0090031 | positive regulation of steroid hormone biosynthetic process(GO:0090031) |
0.1 | 0.2 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
0.1 | 0.1 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.1 | 0.3 | GO:0009629 | response to gravity(GO:0009629) |
0.1 | 0.2 | GO:0090148 | membrane fission(GO:0090148) |
0.1 | 0.1 | GO:0048769 | sarcomerogenesis(GO:0048769) |
0.1 | 0.5 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
0.1 | 1.1 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
0.1 | 0.3 | GO:1903298 | regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903297) negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903298) |
0.1 | 3.1 | GO:0015988 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.1 | 0.3 | GO:1902855 | regulation of nonmotile primary cilium assembly(GO:1902855) |
0.1 | 0.3 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) |
0.1 | 0.3 | GO:0032607 | interferon-alpha production(GO:0032607) |
0.1 | 0.5 | GO:0051415 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.1 | 1.0 | GO:0019985 | translesion synthesis(GO:0019985) |
0.1 | 0.5 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.1 | 0.3 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.1 | 0.2 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.1 | 0.5 | GO:0033014 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
0.1 | 0.8 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.1 | 0.5 | GO:0015871 | choline transport(GO:0015871) |
0.1 | 0.2 | GO:1903912 | negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
0.1 | 0.2 | GO:0033026 | negative regulation of mast cell apoptotic process(GO:0033026) |
0.1 | 0.2 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
0.1 | 0.7 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.1 | 0.1 | GO:0032202 | telomere assembly(GO:0032202) |
0.1 | 0.3 | GO:0014745 | negative regulation of muscle adaptation(GO:0014745) |
0.1 | 0.8 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.1 | 2.1 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.1 | 1.2 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.1 | 0.4 | GO:0048478 | replication fork protection(GO:0048478) |
0.1 | 0.1 | GO:0098722 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) asymmetric stem cell division(GO:0098722) germline stem cell asymmetric division(GO:0098728) |
0.1 | 0.2 | GO:0060664 | epithelial cell proliferation involved in salivary gland morphogenesis(GO:0060664) |
0.1 | 1.9 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.1 | 1.5 | GO:0046688 | response to copper ion(GO:0046688) |
0.1 | 0.1 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
0.1 | 0.1 | GO:0071871 | response to epinephrine(GO:0071871) cellular response to epinephrine stimulus(GO:0071872) |
0.1 | 0.2 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
0.1 | 0.6 | GO:0010225 | response to UV-C(GO:0010225) |
0.1 | 0.2 | GO:0007227 | signal transduction downstream of smoothened(GO:0007227) |
0.1 | 0.2 | GO:2000780 | negative regulation of double-strand break repair(GO:2000780) |
0.1 | 1.1 | GO:0008272 | sulfate transport(GO:0008272) |
0.1 | 0.2 | GO:1900109 | regulation of histone H3-K9 dimethylation(GO:1900109) |
0.1 | 0.3 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.1 | 0.1 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.1 | 0.2 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
0.1 | 0.5 | GO:1904970 | brush border assembly(GO:1904970) |
0.1 | 0.9 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.1 | 0.6 | GO:0043970 | histone H3-K9 acetylation(GO:0043970) |
0.1 | 0.3 | GO:0019086 | late viral transcription(GO:0019086) |
0.1 | 0.3 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.1 | 0.1 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.1 | 0.4 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.1 | 0.5 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.1 | 0.3 | GO:1900147 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
0.1 | 0.3 | GO:0008210 | estrogen metabolic process(GO:0008210) |
0.1 | 0.2 | GO:0048596 | embryonic camera-type eye morphogenesis(GO:0048596) |
0.1 | 0.7 | GO:0061088 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.1 | 0.3 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
0.1 | 0.3 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.1 | 0.2 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.1 | 0.8 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.1 | 0.2 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.1 | 0.4 | GO:0060431 | primary lung bud formation(GO:0060431) |
0.1 | 0.3 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.1 | 0.3 | GO:0019348 | polyprenol metabolic process(GO:0016093) dolichol metabolic process(GO:0019348) |
0.1 | 0.2 | GO:0048143 | astrocyte activation(GO:0048143) |
0.1 | 0.5 | GO:0035810 | positive regulation of urine volume(GO:0035810) |
0.1 | 0.9 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.1 | 0.2 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.1 | 0.2 | GO:1903599 | positive regulation of mitophagy(GO:1903599) |
0.1 | 0.2 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
0.1 | 0.4 | GO:0052405 | modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
0.1 | 0.1 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
0.1 | 1.7 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
0.1 | 0.8 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
0.1 | 0.6 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.1 | 0.2 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.1 | 0.1 | GO:0055069 | zinc ion homeostasis(GO:0055069) |
0.1 | 0.1 | GO:0031627 | telomeric loop formation(GO:0031627) |
0.1 | 0.3 | GO:0019740 | nitrogen utilization(GO:0019740) |
0.1 | 1.5 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.1 | 0.3 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.1 | 0.2 | GO:0051582 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
0.1 | 0.3 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
0.1 | 0.2 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
0.1 | 0.3 | GO:0060676 | ureteric bud formation(GO:0060676) |
0.1 | 0.3 | GO:0002536 | respiratory burst involved in inflammatory response(GO:0002536) |
0.1 | 0.8 | GO:0000394 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.1 | 0.5 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.1 | 0.3 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.1 | 0.3 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.1 | 0.2 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
0.1 | 1.6 | GO:0060074 | synapse maturation(GO:0060074) |
0.1 | 0.4 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.1 | 0.4 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.1 | 0.3 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
0.1 | 0.9 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.1 | 0.4 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.1 | 1.4 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.1 | 0.2 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.1 | 0.3 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.1 | 0.2 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
0.1 | 1.4 | GO:0030488 | tRNA methylation(GO:0030488) |
0.1 | 0.2 | GO:0015793 | glycerol transport(GO:0015793) |
0.1 | 0.6 | GO:0031498 | chromatin disassembly(GO:0031498) |
0.1 | 0.2 | GO:0072711 | response to hydroxyurea(GO:0072710) cellular response to hydroxyurea(GO:0072711) |
0.1 | 0.5 | GO:0015919 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.1 | 0.8 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.1 | 0.2 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
0.1 | 0.2 | GO:1903975 | regulation of glial cell migration(GO:1903975) |
0.1 | 0.2 | GO:0046104 | thymidine metabolic process(GO:0046104) |
0.1 | 0.1 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) negative regulation of Schwann cell proliferation(GO:0010626) |
0.1 | 0.2 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) |
0.1 | 0.4 | GO:0042994 | cytoplasmic sequestering of transcription factor(GO:0042994) |
0.1 | 0.2 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
0.1 | 0.2 | GO:0072393 | microtubule anchoring at microtubule organizing center(GO:0072393) |
0.1 | 0.2 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.1 | 0.3 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
0.1 | 0.3 | GO:0009838 | abscission(GO:0009838) |
0.1 | 1.5 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.1 | 0.2 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
0.1 | 2.4 | GO:0031018 | endocrine pancreas development(GO:0031018) |
0.1 | 0.6 | GO:2000479 | regulation of cAMP-dependent protein kinase activity(GO:2000479) |
0.1 | 0.1 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
0.1 | 1.4 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.1 | 1.0 | GO:1990403 | embryonic brain development(GO:1990403) |
0.1 | 0.2 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.1 | 0.2 | GO:0070669 | response to interleukin-2(GO:0070669) |
0.1 | 0.4 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.1 | 0.4 | GO:0044030 | regulation of DNA methylation(GO:0044030) |
0.1 | 0.2 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.1 | 0.3 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.1 | 0.2 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
0.1 | 0.2 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.1 | 1.0 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.1 | 0.1 | GO:0006555 | methionine metabolic process(GO:0006555) |
0.1 | 0.2 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) synaptic growth at neuromuscular junction(GO:0051124) |
0.1 | 0.1 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
0.1 | 0.7 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.1 | 0.1 | GO:0036302 | atrioventricular canal development(GO:0036302) |
0.1 | 0.1 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.1 | 0.1 | GO:0043091 | L-arginine import(GO:0043091) arginine import(GO:0090467) L-arginine transport(GO:1902023) |
0.1 | 0.1 | GO:0000436 | carbon catabolite regulation of transcription from RNA polymerase II promoter(GO:0000429) carbon catabolite activation of transcription from RNA polymerase II promoter(GO:0000436) |
0.1 | 0.5 | GO:0032329 | serine transport(GO:0032329) |
0.1 | 0.3 | GO:0038030 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.1 | 0.2 | GO:0007440 | foregut morphogenesis(GO:0007440) embryonic foregut morphogenesis(GO:0048617) |
0.1 | 0.1 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.1 | 0.1 | GO:0003176 | aortic valve development(GO:0003176) aortic valve morphogenesis(GO:0003180) |
0.1 | 1.0 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.1 | 0.1 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.1 | 0.4 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.1 | 0.1 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
0.1 | 0.1 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.1 | 0.9 | GO:0006110 | regulation of glycolytic process(GO:0006110) |
0.1 | 0.3 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.1 | 0.1 | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
0.1 | 0.3 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
0.1 | 1.0 | GO:0009303 | rRNA transcription(GO:0009303) |
0.1 | 0.2 | GO:0090151 | establishment of protein localization to mitochondrial membrane(GO:0090151) |
0.1 | 0.6 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.1 | 0.1 | GO:0010749 | regulation of nitric oxide mediated signal transduction(GO:0010749) |
0.1 | 0.6 | GO:0097320 | membrane tubulation(GO:0097320) |
0.1 | 0.1 | GO:0001555 | oocyte growth(GO:0001555) |
0.1 | 0.1 | GO:0051799 | negative regulation of hair follicle development(GO:0051799) |
0.1 | 0.1 | GO:0034441 | plasma lipoprotein particle oxidation(GO:0034441) |
0.1 | 0.3 | GO:0043144 | snoRNA processing(GO:0043144) |
0.1 | 0.1 | GO:0048370 | lateral mesoderm morphogenesis(GO:0048369) lateral mesoderm formation(GO:0048370) lateral mesodermal cell differentiation(GO:0048371) |
0.1 | 0.2 | GO:0014744 | positive regulation of muscle adaptation(GO:0014744) |
0.1 | 0.6 | GO:0034377 | plasma lipoprotein particle assembly(GO:0034377) |
0.1 | 0.4 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.1 | 0.1 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
0.1 | 0.2 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.1 | 0.6 | GO:0032060 | bleb assembly(GO:0032060) |
0.1 | 0.5 | GO:0030878 | thyroid gland development(GO:0030878) |
0.1 | 0.9 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
0.1 | 0.3 | GO:0051639 | actin filament network formation(GO:0051639) |
0.1 | 0.1 | GO:0044704 | single-organism reproductive behavior(GO:0044704) |
0.1 | 0.3 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.1 | 0.6 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.1 | 0.1 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
0.1 | 0.3 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.1 | 0.1 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.1 | 0.1 | GO:0034635 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
0.1 | 0.1 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.1 | 0.3 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.1 | 0.5 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.1 | 0.1 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.1 | 0.1 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.1 | 0.2 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
0.1 | 0.1 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.1 | 0.1 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.1 | 0.1 | GO:0032071 | regulation of endodeoxyribonuclease activity(GO:0032071) |
0.1 | 0.4 | GO:0051657 | maintenance of organelle location(GO:0051657) |
0.1 | 0.5 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.1 | 0.2 | GO:0021699 | cerebellar cortex maturation(GO:0021699) |
0.1 | 0.4 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.1 | 0.5 | GO:0090201 | negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
0.1 | 0.3 | GO:0034080 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.1 | 0.2 | GO:1900378 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.1 | 0.1 | GO:1903208 | neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
0.1 | 0.4 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.1 | 0.2 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.1 | 0.2 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
0.1 | 2.5 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.1 | 0.1 | GO:0060685 | regulation of prostatic bud formation(GO:0060685) negative regulation of prostatic bud formation(GO:0060686) |
0.1 | 0.6 | GO:0006152 | purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
0.1 | 0.6 | GO:1904874 | regulation of telomerase RNA localization to Cajal body(GO:1904872) positive regulation of telomerase RNA localization to Cajal body(GO:1904874) |
0.1 | 0.2 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.1 | 0.6 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.1 | 0.9 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.1 | 0.1 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.1 | 0.2 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.1 | 0.1 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
0.1 | 0.1 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.1 | 0.6 | GO:0001710 | mesodermal cell fate commitment(GO:0001710) |
0.1 | 0.1 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.1 | 0.1 | GO:0021603 | cranial nerve formation(GO:0021603) |
0.1 | 0.2 | GO:0070391 | response to lipoteichoic acid(GO:0070391) cellular response to lipoteichoic acid(GO:0071223) |
0.1 | 0.1 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.1 | 0.1 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.1 | 2.4 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.1 | 0.6 | GO:0010165 | response to X-ray(GO:0010165) |
0.1 | 0.2 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.1 | 0.3 | GO:0097152 | mesenchymal cell apoptotic process(GO:0097152) |
0.1 | 0.5 | GO:0010388 | cullin deneddylation(GO:0010388) |
0.1 | 0.4 | GO:0051220 | cytoplasmic sequestering of protein(GO:0051220) |
0.1 | 0.1 | GO:0034241 | positive regulation of macrophage fusion(GO:0034241) |
0.1 | 2.5 | GO:0006892 | post-Golgi vesicle-mediated transport(GO:0006892) |
0.1 | 0.3 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.1 | 0.2 | GO:0036233 | glycine import(GO:0036233) |
0.1 | 0.9 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.1 | 0.1 | GO:2000836 | androgen secretion(GO:0035935) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) |
0.1 | 0.4 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.1 | 0.3 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.1 | 0.1 | GO:2000758 | positive regulation of peptidyl-lysine acetylation(GO:2000758) |
0.1 | 0.5 | GO:0036336 | dendritic cell migration(GO:0036336) |
0.1 | 0.1 | GO:0032252 | secretory granule localization(GO:0032252) |
0.1 | 0.6 | GO:0006743 | ubiquinone metabolic process(GO:0006743) |
0.1 | 0.2 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.1 | 0.6 | GO:0006465 | signal peptide processing(GO:0006465) |
0.1 | 2.0 | GO:0006986 | response to unfolded protein(GO:0006986) |
0.1 | 0.2 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.1 | 0.1 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
0.1 | 0.1 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
0.1 | 0.1 | GO:0071569 | protein ufmylation(GO:0071569) protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.1 | 0.1 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.1 | 0.1 | GO:0043382 | positive regulation of memory T cell differentiation(GO:0043382) |
0.1 | 0.2 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
0.1 | 0.1 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.1 | 0.3 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.1 | 0.1 | GO:0002097 | tRNA wobble base modification(GO:0002097) |
0.1 | 0.5 | GO:1901739 | regulation of myoblast fusion(GO:1901739) |
0.1 | 0.3 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.1 | 0.1 | GO:0006984 | ER-nucleus signaling pathway(GO:0006984) |
0.1 | 0.1 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
0.1 | 0.1 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
0.1 | 0.3 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.1 | 0.1 | GO:0060454 | positive regulation of gastric acid secretion(GO:0060454) |
0.1 | 0.1 | GO:0050955 | thermoception(GO:0050955) |
0.1 | 1.0 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.1 | 0.3 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.1 | 0.3 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.1 | 0.1 | GO:0019042 | viral latency(GO:0019042) |
0.1 | 0.2 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
0.1 | 0.5 | GO:0002192 | IRES-dependent translational initiation(GO:0002192) |
0.1 | 1.2 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.1 | 0.4 | GO:0016446 | somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.1 | 0.8 | GO:0072661 | protein targeting to plasma membrane(GO:0072661) |
0.1 | 0.1 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.1 | 0.1 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.1 | 0.2 | GO:0000237 | leptotene(GO:0000237) |
0.1 | 0.2 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.1 | 0.1 | GO:0032096 | negative regulation of response to food(GO:0032096) |
0.1 | 0.3 | GO:1902260 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
0.1 | 0.2 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
0.1 | 0.1 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
0.1 | 0.3 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.1 | 0.1 | GO:0050957 | equilibrioception(GO:0050957) |
0.1 | 0.2 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.1 | 0.2 | GO:0018343 | protein farnesylation(GO:0018343) |
0.1 | 0.1 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) |
0.1 | 0.2 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.1 | 0.1 | GO:0002679 | respiratory burst involved in defense response(GO:0002679) |
0.1 | 0.3 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.1 | 1.0 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.1 | 0.4 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.1 | 0.1 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.1 | 0.4 | GO:0021683 | cerebellar granular layer morphogenesis(GO:0021683) |
0.1 | 0.2 | GO:0060283 | negative regulation of oocyte development(GO:0060283) |
0.1 | 0.2 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.1 | 0.1 | GO:0002070 | epithelial cell maturation(GO:0002070) |
0.1 | 0.3 | GO:0070207 | protein homotrimerization(GO:0070207) |
0.1 | 0.2 | GO:0043584 | nose development(GO:0043584) |
0.1 | 0.1 | GO:0071926 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.1 | 0.4 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.1 | 0.1 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.1 | 0.2 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.1 | 0.3 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.1 | 0.3 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.1 | 0.6 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.1 | 0.2 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.1 | 0.1 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.1 | 0.1 | GO:0060430 | lung saccule development(GO:0060430) |
0.1 | 0.9 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.1 | 0.1 | GO:1904251 | regulation of bile acid metabolic process(GO:1904251) |
0.1 | 0.4 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
0.1 | 0.1 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.1 | 1.1 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.1 | 0.4 | GO:0031440 | regulation of mRNA 3'-end processing(GO:0031440) |
0.1 | 0.6 | GO:0045116 | protein neddylation(GO:0045116) |
0.1 | 0.3 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.1 | 0.4 | GO:1904322 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.1 | 0.1 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.0 | 0.1 | GO:0035963 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.0 | 0.1 | GO:1900125 | regulation of hyaluronan biosynthetic process(GO:1900125) |
0.0 | 0.2 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.0 | 0.2 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.0 | 0.0 | GO:0033153 | somatic diversification of T cell receptor genes(GO:0002568) somatic recombination of T cell receptor gene segments(GO:0002681) T cell receptor V(D)J recombination(GO:0033153) |
0.0 | 0.4 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.0 | 0.4 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.0 | 1.1 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.0 | 0.5 | GO:0044406 | adhesion of symbiont to host(GO:0044406) |
0.0 | 0.3 | GO:0072112 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.0 | 0.3 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.0 | 0.6 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.0 | 0.1 | GO:0030035 | microspike assembly(GO:0030035) |
0.0 | 0.0 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
0.0 | 0.1 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.0 | 0.6 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
0.0 | 0.5 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.0 | 0.1 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
0.0 | 0.2 | GO:0051571 | positive regulation of histone H3-K4 methylation(GO:0051571) |
0.0 | 0.1 | GO:1900135 | positive regulation of renin secretion into blood stream(GO:1900135) |
0.0 | 0.1 | GO:0032621 | interleukin-18 production(GO:0032621) |
0.0 | 0.3 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.0 | 0.7 | GO:0042403 | thyroid hormone metabolic process(GO:0042403) |
0.0 | 1.0 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.0 | 0.0 | GO:0035413 | positive regulation of catenin import into nucleus(GO:0035413) |
0.0 | 0.1 | GO:0003348 | cardiac endothelial cell differentiation(GO:0003348) |
0.0 | 0.3 | GO:0006706 | steroid catabolic process(GO:0006706) |
0.0 | 0.3 | GO:0044065 | regulation of respiratory system process(GO:0044065) |
0.0 | 0.5 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.0 | 0.0 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.0 | 1.6 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.0 | 0.1 | GO:0051383 | kinetochore organization(GO:0051383) |
0.0 | 0.4 | GO:0003298 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.0 | 1.5 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.0 | 0.4 | GO:0099500 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
0.0 | 1.5 | GO:0032465 | regulation of cytokinesis(GO:0032465) |
0.0 | 0.0 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
0.0 | 0.3 | GO:0044146 | negative regulation of growth of symbiont in host(GO:0044130) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
0.0 | 0.0 | GO:0040001 | establishment of mitotic spindle localization(GO:0040001) |
0.0 | 0.2 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.0 | 0.1 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.0 | 0.2 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.0 | 0.0 | GO:1903795 | regulation of inorganic anion transmembrane transport(GO:1903795) positive regulation of inorganic anion transmembrane transport(GO:1903797) |
0.0 | 0.0 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.0 | 0.1 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
0.0 | 0.1 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
0.0 | 0.1 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
0.0 | 0.2 | GO:0031033 | myosin filament organization(GO:0031033) |
0.0 | 0.2 | GO:0045540 | regulation of cholesterol biosynthetic process(GO:0045540) |
0.0 | 0.3 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.0 | 0.1 | GO:0001302 | replicative cell aging(GO:0001302) |
0.0 | 0.3 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.0 | 0.2 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.0 | 0.1 | GO:1900004 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.0 | 0.1 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.0 | 0.2 | GO:0051031 | tRNA transport(GO:0051031) |
0.0 | 0.1 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.0 | 0.2 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.0 | 0.2 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.0 | 0.2 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.0 | 0.2 | GO:0060742 | epithelial cell differentiation involved in prostate gland development(GO:0060742) |
0.0 | 0.2 | GO:0046628 | positive regulation of insulin receptor signaling pathway(GO:0046628) |
0.0 | 0.0 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.0 | 0.1 | GO:0043090 | amino acid import(GO:0043090) |
0.0 | 0.1 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.0 | 0.1 | GO:0030421 | defecation(GO:0030421) |
0.0 | 0.2 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.0 | 0.3 | GO:0000132 | establishment of mitotic spindle orientation(GO:0000132) |
0.0 | 0.1 | GO:0048333 | mesodermal cell differentiation(GO:0048333) |
0.0 | 0.7 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.0 | 0.2 | GO:0042523 | positive regulation of tyrosine phosphorylation of Stat5 protein(GO:0042523) |
0.0 | 0.1 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
0.0 | 0.1 | GO:0030728 | ovulation(GO:0030728) |
0.0 | 0.1 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
0.0 | 1.2 | GO:0001895 | retina homeostasis(GO:0001895) |
0.0 | 0.3 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.0 | 0.0 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.0 | 0.1 | GO:0060399 | regulation of growth hormone receptor signaling pathway(GO:0060398) positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.0 | 0.0 | GO:2000810 | regulation of bicellular tight junction assembly(GO:2000810) |
0.0 | 0.1 | GO:1904667 | negative regulation of ubiquitin protein ligase activity(GO:1904667) |
0.0 | 0.2 | GO:2000144 | positive regulation of DNA-templated transcription, initiation(GO:2000144) |
0.0 | 0.0 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.0 | 0.1 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
0.0 | 0.2 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.0 | 0.1 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
0.0 | 0.1 | GO:0032367 | intracellular cholesterol transport(GO:0032367) |
0.0 | 0.1 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.0 | 0.2 | GO:0001842 | neural fold formation(GO:0001842) |
0.0 | 0.0 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
0.0 | 0.2 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.0 | 0.1 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.0 | 0.0 | GO:0032100 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
0.0 | 0.0 | GO:0071476 | cellular hypotonic response(GO:0071476) |
0.0 | 0.2 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.0 | 0.2 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.0 | 0.5 | GO:0060046 | regulation of acrosome reaction(GO:0060046) |
0.0 | 0.2 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
0.0 | 0.6 | GO:0048240 | sperm capacitation(GO:0048240) |
0.0 | 0.1 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.0 | 0.1 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.0 | 0.1 | GO:1900153 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
0.0 | 0.1 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.0 | 0.1 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
0.0 | 0.1 | GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.0 | 0.1 | GO:0003198 | epithelial to mesenchymal transition involved in endocardial cushion formation(GO:0003198) |
0.0 | 0.6 | GO:0042246 | tissue regeneration(GO:0042246) |
0.0 | 0.1 | GO:0008105 | asymmetric protein localization(GO:0008105) |
0.0 | 0.2 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.0 | 0.1 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
0.0 | 0.1 | GO:2000598 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.0 | 0.1 | GO:0060285 | cilium or flagellum-dependent cell motility(GO:0001539) cilium-dependent cell motility(GO:0060285) |
0.0 | 0.1 | GO:0010875 | positive regulation of cholesterol efflux(GO:0010875) |
0.0 | 0.1 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.0 | 0.1 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.0 | 0.1 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.0 | 0.3 | GO:0014904 | myotube cell development(GO:0014904) |
0.0 | 0.2 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.0 | 0.1 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.0 | 0.0 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
0.0 | 0.1 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
0.0 | 0.6 | GO:0006400 | tRNA modification(GO:0006400) |
0.0 | 0.1 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
0.0 | 0.0 | GO:2000678 | negative regulation of transcription regulatory region DNA binding(GO:2000678) |
0.0 | 0.2 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.0 | 0.1 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.0 | 0.3 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.0 | 0.3 | GO:0007007 | inner mitochondrial membrane organization(GO:0007007) |
0.0 | 0.3 | GO:0030520 | intracellular estrogen receptor signaling pathway(GO:0030520) |
0.0 | 0.2 | GO:0060044 | negative regulation of cardiac muscle cell proliferation(GO:0060044) |
0.0 | 0.1 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.0 | 0.0 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.0 | 0.7 | GO:0001825 | blastocyst formation(GO:0001825) |
0.0 | 0.0 | GO:0042532 | negative regulation of tyrosine phosphorylation of STAT protein(GO:0042532) |
0.0 | 0.2 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.0 | 0.0 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
0.0 | 0.0 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.0 | 0.3 | GO:0050685 | positive regulation of mRNA processing(GO:0050685) |
0.0 | 0.2 | GO:0006108 | malate metabolic process(GO:0006108) |
0.0 | 0.4 | GO:0006303 | double-strand break repair via nonhomologous end joining(GO:0006303) |
0.0 | 0.1 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.0 | 0.1 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.0 | 0.8 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.0 | 0.0 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.0 | 0.1 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.0 | 0.1 | GO:0097384 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) cellular lipid biosynthetic process(GO:0097384) ether biosynthetic process(GO:1901503) |
0.0 | 0.1 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
0.0 | 0.1 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.0 | 0.1 | GO:0071379 | cellular response to prostaglandin stimulus(GO:0071379) |
0.0 | 0.1 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.0 | 0.3 | GO:0002092 | positive regulation of receptor internalization(GO:0002092) |
0.0 | 0.1 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.0 | 0.1 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
0.0 | 0.2 | GO:0045075 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.0 | 0.1 | GO:0045226 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.0 | 0.1 | GO:0002215 | defense response to nematode(GO:0002215) |
0.0 | 0.1 | GO:0001969 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) |
0.0 | 0.1 | GO:0009414 | response to water deprivation(GO:0009414) |
0.0 | 0.2 | GO:0042438 | melanin metabolic process(GO:0006582) melanin biosynthetic process(GO:0042438) |
0.0 | 0.1 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.0 | 0.1 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.0 | 0.3 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.0 | 0.0 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) |
0.0 | 0.2 | GO:0002084 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.0 | 0.1 | GO:0051140 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
0.0 | 0.1 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.0 | 0.1 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.0 | 0.2 | GO:0048662 | negative regulation of smooth muscle cell proliferation(GO:0048662) |
0.0 | 0.3 | GO:0015858 | nucleoside transport(GO:0015858) |
0.0 | 3.3 | GO:0071230 | cellular response to amino acid stimulus(GO:0071230) |
0.0 | 0.1 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.0 | 0.1 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.0 | 0.1 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.0 | 0.0 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.0 | 0.2 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.0 | 0.3 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.0 | 0.0 | GO:0031125 | rRNA 3'-end processing(GO:0031125) |
0.0 | 0.1 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.0 | 0.0 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.0 | 0.0 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
0.0 | 0.2 | GO:0035743 | CD4-positive, alpha-beta T cell cytokine production(GO:0035743) |
0.0 | 0.1 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.0 | 0.4 | GO:0007099 | centriole replication(GO:0007099) |
0.0 | 0.1 | GO:0071435 | potassium ion export(GO:0071435) |
0.0 | 0.0 | GO:0046878 | positive regulation of saliva secretion(GO:0046878) |
0.0 | 0.0 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.0 | 0.1 | GO:0090155 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
0.0 | 0.4 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.0 | 0.7 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
0.0 | 0.0 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.0 | 0.1 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.0 | 0.1 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
0.0 | 0.1 | GO:0060037 | pharyngeal system development(GO:0060037) |
0.0 | 0.0 | GO:0014832 | urinary bladder smooth muscle contraction(GO:0014832) |
0.0 | 0.1 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.0 | 0.2 | GO:0036119 | response to platelet-derived growth factor(GO:0036119) cellular response to platelet-derived growth factor stimulus(GO:0036120) |
0.0 | 0.4 | GO:0036075 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.0 | 0.1 | GO:0046836 | glycolipid transport(GO:0046836) |
0.0 | 0.3 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
0.0 | 0.1 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.0 | 0.0 | GO:1903573 | negative regulation of response to endoplasmic reticulum stress(GO:1903573) |
0.0 | 0.1 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.0 | 0.0 | GO:0032095 | regulation of response to food(GO:0032095) |
0.0 | 0.1 | GO:0050961 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.0 | 0.1 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.0 | 0.2 | GO:0015874 | norepinephrine transport(GO:0015874) |
0.0 | 0.4 | GO:0010842 | retina layer formation(GO:0010842) |
0.0 | 0.0 | GO:0034375 | high-density lipoprotein particle remodeling(GO:0034375) |
0.0 | 0.1 | GO:0009249 | protein lipoylation(GO:0009249) |
0.0 | 0.6 | GO:0045669 | positive regulation of osteoblast differentiation(GO:0045669) |
0.0 | 0.3 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.0 | 0.3 | GO:0022904 | respiratory electron transport chain(GO:0022904) |
0.0 | 0.0 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.0 | 0.0 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.0 | 0.1 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
0.0 | 0.0 | GO:0036003 | positive regulation of transcription from RNA polymerase II promoter in response to stress(GO:0036003) |
0.0 | 0.0 | GO:0019230 | proprioception(GO:0019230) |
0.0 | 0.1 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.0 | 0.1 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.0 | 0.1 | GO:0003330 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
0.0 | 0.4 | GO:0051057 | positive regulation of small GTPase mediated signal transduction(GO:0051057) |
0.0 | 0.1 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
0.0 | 0.0 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.0 | 0.1 | GO:1901186 | positive regulation of ERBB signaling pathway(GO:1901186) |
0.0 | 0.1 | GO:0071467 | cellular response to pH(GO:0071467) |
0.0 | 0.1 | GO:1902004 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
0.0 | 0.1 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.0 | 0.0 | GO:0061110 | dense core granule biogenesis(GO:0061110) |
0.0 | 0.1 | GO:0051601 | exocyst localization(GO:0051601) |
0.0 | 0.2 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.0 | 0.1 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
0.0 | 0.1 | GO:0009186 | deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
0.0 | 0.1 | GO:0070986 | left/right axis specification(GO:0070986) |
0.0 | 0.1 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.0 | 0.1 | GO:0014889 | muscle atrophy(GO:0014889) |
0.0 | 0.1 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.0 | 0.1 | GO:0006007 | glucose catabolic process(GO:0006007) |
0.0 | 0.2 | GO:0045187 | regulation of circadian sleep/wake cycle, sleep(GO:0045187) |
0.0 | 0.1 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.0 | 0.5 | GO:0034605 | cellular response to heat(GO:0034605) |
0.0 | 0.2 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.0 | 0.2 | GO:0007144 | female meiosis I(GO:0007144) |
0.0 | 0.1 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.0 | 0.0 | GO:1903224 | regulation of endodermal cell differentiation(GO:1903224) |
0.0 | 0.2 | GO:0000578 | embryonic axis specification(GO:0000578) |
0.0 | 0.0 | GO:0002540 | leukotriene production involved in inflammatory response(GO:0002540) |
0.0 | 0.0 | GO:0035106 | operant conditioning(GO:0035106) |
0.0 | 0.0 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.0 | 0.0 | GO:0032225 | regulation of synaptic transmission, dopaminergic(GO:0032225) |
0.0 | 0.1 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.0 | 1.2 | GO:0006694 | steroid biosynthetic process(GO:0006694) |
0.0 | 0.1 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
0.0 | 0.0 | GO:0032332 | positive regulation of chondrocyte differentiation(GO:0032332) |
0.0 | 0.0 | GO:0051176 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of sulfur metabolic process(GO:0051176) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.0 | 0.1 | GO:0060467 | negative regulation of fertilization(GO:0060467) prevention of polyspermy(GO:0060468) |
0.0 | 0.0 | GO:0033079 | immature T cell proliferation(GO:0033079) |
0.0 | 0.0 | GO:0070170 | regulation of tooth mineralization(GO:0070170) |
0.0 | 0.1 | GO:0014029 | neural crest formation(GO:0014029) |
0.0 | 0.0 | GO:0035337 | fatty-acyl-CoA metabolic process(GO:0035337) |
0.0 | 0.0 | GO:1904526 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.0 | 0.1 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.0 | 0.1 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.0 | 0.2 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
0.0 | 0.0 | GO:0072498 | embryonic skeletal joint development(GO:0072498) |
0.0 | 0.0 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
0.0 | 0.0 | GO:0070813 | hydrogen sulfide metabolic process(GO:0070813) |
0.0 | 0.1 | GO:0046184 | aldehyde biosynthetic process(GO:0046184) |
0.0 | 0.1 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.0 | 0.0 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.0 | 0.1 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.0 | 0.0 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
0.0 | 0.1 | GO:0071420 | cellular response to histamine(GO:0071420) |
0.0 | 0.4 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.0 | 0.0 | GO:0044036 | cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
0.0 | 0.1 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.0 | 0.0 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.0 | 0.0 | GO:0021559 | trigeminal nerve development(GO:0021559) |
0.0 | 0.0 | GO:0033630 | positive regulation of cell adhesion mediated by integrin(GO:0033630) |
0.0 | 0.0 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.0 | 0.7 | GO:0060113 | inner ear receptor cell differentiation(GO:0060113) |
0.0 | 0.0 | GO:0072025 | distal convoluted tubule development(GO:0072025) DCT cell differentiation(GO:0072069) metanephric distal convoluted tubule development(GO:0072221) metanephric distal tubule development(GO:0072235) metanephric DCT cell differentiation(GO:0072240) |
0.0 | 0.1 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.0 | 0.2 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.0 | 0.1 | GO:0003356 | regulation of cilium beat frequency(GO:0003356) |
0.0 | 0.0 | GO:0035336 | long-chain fatty-acyl-CoA metabolic process(GO:0035336) |
0.0 | 1.0 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.0 | 0.1 | GO:0033227 | dsRNA transport(GO:0033227) |
0.0 | 0.0 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
0.0 | 0.0 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.0 | 0.0 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
0.0 | 0.2 | GO:0015727 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.0 | 0.0 | GO:2000020 | positive regulation of male gonad development(GO:2000020) |
0.0 | 0.0 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
0.0 | 0.1 | GO:0030501 | positive regulation of bone mineralization(GO:0030501) positive regulation of biomineral tissue development(GO:0070169) |
0.0 | 0.1 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.0 | 0.1 | GO:0030853 | negative regulation of granulocyte differentiation(GO:0030853) |
0.0 | 0.0 | GO:0044550 | secondary metabolite biosynthetic process(GO:0044550) |
0.0 | 0.1 | GO:0071625 | vocalization behavior(GO:0071625) |
0.0 | 0.1 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
0.0 | 0.2 | GO:0050686 | negative regulation of mRNA processing(GO:0050686) |
0.0 | 0.1 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
0.0 | 0.0 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
0.0 | 0.1 | GO:1901673 | regulation of spindle assembly(GO:0090169) regulation of mitotic spindle assembly(GO:1901673) |
0.0 | 0.0 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.0 | 0.3 | GO:0060259 | regulation of feeding behavior(GO:0060259) |
0.0 | 0.1 | GO:0007000 | nucleolus organization(GO:0007000) |
0.0 | 0.0 | GO:0019359 | nicotinamide nucleotide biosynthetic process(GO:0019359) |
0.0 | 0.2 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
0.0 | 0.2 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.0 | 0.1 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
0.0 | 0.0 | GO:0051593 | response to folic acid(GO:0051593) |
0.0 | 0.0 | GO:2000468 | regulation of peroxidase activity(GO:2000468) |
0.0 | 0.0 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.0 | 0.1 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.0 | 0.1 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.0 | 0.1 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.0 | 0.4 | GO:0007200 | phospholipase C-activating G-protein coupled receptor signaling pathway(GO:0007200) |
0.0 | 0.0 | GO:0042167 | heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.0 | 0.0 | GO:2000194 | regulation of female gonad development(GO:2000194) |
0.0 | 0.0 | GO:0042659 | regulation of cell fate specification(GO:0042659) |
0.0 | 0.0 | GO:0045023 | G0 to G1 transition(GO:0045023) regulation of G0 to G1 transition(GO:0070316) |
0.0 | 0.0 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.0 | 0.1 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.0 | 0.0 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) |
0.0 | 0.1 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
0.0 | 0.1 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.0 | 0.1 | GO:0031297 | replication fork processing(GO:0031297) |
0.0 | 0.0 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
0.0 | 0.0 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.0 | 0.0 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.0 | 0.0 | GO:1900736 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.0 | 0.1 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.0 | 0.4 | GO:0016125 | sterol metabolic process(GO:0016125) |
0.0 | 0.0 | GO:0009146 | purine nucleoside triphosphate catabolic process(GO:0009146) |
0.0 | 0.6 | GO:0006402 | mRNA catabolic process(GO:0006402) |
0.0 | 0.0 | GO:0002576 | platelet degranulation(GO:0002576) |
0.0 | 0.0 | GO:0072610 | interleukin-12 secretion(GO:0072610) |
0.0 | 0.1 | GO:0008216 | spermidine metabolic process(GO:0008216) |
0.0 | 0.0 | GO:1900107 | regulation of nodal signaling pathway(GO:1900107) |
0.0 | 0.1 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
0.0 | 0.0 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.0 | 0.0 | GO:0032196 | transposition(GO:0032196) |
0.0 | 0.0 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.0 | 1.2 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.0 | 0.0 | GO:0033145 | positive regulation of intracellular steroid hormone receptor signaling pathway(GO:0033145) |
0.0 | 0.0 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.0 | 0.0 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
0.0 | 0.4 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) |
0.0 | 0.0 | GO:1902744 | negative regulation of lamellipodium organization(GO:1902744) |
0.0 | 0.1 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.0 | 0.0 | GO:0021593 | rhombomere morphogenesis(GO:0021593) |
0.0 | 0.0 | GO:0039692 | single stranded viral RNA replication via double stranded DNA intermediate(GO:0039692) |
0.0 | 0.0 | GO:0003010 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) |
0.0 | 0.0 | GO:0009310 | polyamine catabolic process(GO:0006598) amine catabolic process(GO:0009310) cellular biogenic amine catabolic process(GO:0042402) |
0.0 | 0.0 | GO:1990314 | cellular response to insulin-like growth factor stimulus(GO:1990314) |
0.0 | 0.0 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.0 | 0.0 | GO:0046500 | S-adenosylmethionine metabolic process(GO:0046500) |
0.0 | 0.2 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.0 | 0.1 | GO:0042044 | fluid transport(GO:0042044) |
0.0 | 0.0 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
0.0 | 0.0 | GO:0034551 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.0 | 0.5 | GO:0006475 | internal protein amino acid acetylation(GO:0006475) |
0.0 | 0.1 | GO:0030049 | muscle filament sliding(GO:0030049) |
0.0 | 0.1 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.0 | 0.0 | GO:0017004 | cytochrome complex assembly(GO:0017004) |
0.0 | 0.0 | GO:0006901 | vesicle coating(GO:0006901) |
0.0 | 0.1 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.0 | 0.1 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.0 | 0.0 | GO:0035635 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.0 | 0.0 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.0 | 0.0 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.0 | 0.1 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.0 | 0.0 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.0 | 0.1 | GO:0032786 | positive regulation of DNA-templated transcription, elongation(GO:0032786) |
0.0 | 0.0 | GO:0008355 | olfactory learning(GO:0008355) |
0.0 | 0.0 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.0 | 0.0 | GO:0060023 | soft palate development(GO:0060023) |
0.0 | 0.1 | GO:0032277 | negative regulation of gonadotropin secretion(GO:0032277) |
0.0 | 0.1 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.0 | 0.6 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.0 | 0.0 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.0 | 0.0 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.0 | 0.0 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.0 | 0.1 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.0 | 0.3 | GO:0001662 | behavioral fear response(GO:0001662) |
0.0 | 0.0 | GO:0097421 | liver regeneration(GO:0097421) |
0.0 | 0.0 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.0 | 0.0 | GO:0060979 | vasculogenesis involved in coronary vascular morphogenesis(GO:0060979) |
0.0 | 0.2 | GO:0009166 | nucleotide catabolic process(GO:0009166) |
0.0 | 0.1 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.0 | 0.1 | GO:0072512 | ferric iron transport(GO:0015682) trivalent inorganic cation transport(GO:0072512) |
0.0 | 0.3 | GO:0045103 | intermediate filament-based process(GO:0045103) |
0.0 | 0.0 | GO:0010840 | regulation of circadian sleep/wake cycle, wakefulness(GO:0010840) circadian sleep/wake cycle, wakefulness(GO:0042746) |
0.0 | 0.0 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.0 | 0.0 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.0 | 0.1 | GO:0097237 | cellular response to toxic substance(GO:0097237) |
0.0 | 0.0 | GO:0042517 | positive regulation of tyrosine phosphorylation of Stat3 protein(GO:0042517) |
0.0 | 0.2 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.0 | 0.0 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.0 | 0.1 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.0 | 0.1 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.0 | 0.0 | GO:0060618 | nipple development(GO:0060618) |
0.0 | 0.0 | GO:0000963 | mitochondrial RNA processing(GO:0000963) |
0.0 | 0.0 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.0 | 0.0 | GO:0086012 | membrane depolarization during cardiac muscle cell action potential(GO:0086012) |
0.0 | 0.0 | GO:0021530 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
0.0 | 0.5 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.0 | 0.1 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.0 | 0.0 | GO:0033522 | histone H2A ubiquitination(GO:0033522) |
0.0 | 0.0 | GO:0033860 | regulation of NAD(P)H oxidase activity(GO:0033860) |
0.0 | 0.1 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
0.0 | 0.0 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.0 | 0.4 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
0.0 | 0.2 | GO:0003407 | neural retina development(GO:0003407) |
0.0 | 0.0 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.0 | 0.6 | GO:1903749 | positive regulation of establishment of protein localization to mitochondrion(GO:1903749) |
0.0 | 0.1 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
0.0 | 0.1 | GO:0042538 | hyperosmotic salinity response(GO:0042538) |
0.0 | 0.1 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.0 | 0.1 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.0 | 0.0 | GO:1904429 | regulation of t-circle formation(GO:1904429) |
0.0 | 0.4 | GO:0007030 | Golgi organization(GO:0007030) |
0.0 | 0.0 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.0 | 0.0 | GO:0001774 | microglial cell activation(GO:0001774) |
0.0 | 0.1 | GO:0042255 | ribosome assembly(GO:0042255) |
0.0 | 0.0 | GO:0034435 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
0.0 | 0.0 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.0 | 0.0 | GO:0002767 | immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
0.0 | 0.4 | GO:0007368 | determination of left/right symmetry(GO:0007368) |
0.0 | 0.0 | GO:0045778 | positive regulation of ossification(GO:0045778) |
0.0 | 0.1 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.0 | 0.0 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.0 | 0.0 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.0 | 0.0 | GO:0070427 | regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070424) nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070428) regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070432) |
0.0 | 0.0 | GO:0070286 | axonemal dynein complex assembly(GO:0070286) |
0.0 | 0.0 | GO:2000505 | regulation of energy homeostasis(GO:2000505) |
0.0 | 0.0 | GO:0072093 | metanephric renal vesicle formation(GO:0072093) |
0.0 | 0.0 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.0 | 0.0 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.0 | 0.1 | GO:0007032 | endosome organization(GO:0007032) |
0.0 | 0.0 | GO:0071398 | cellular response to fatty acid(GO:0071398) |
0.0 | 0.0 | GO:0048520 | positive regulation of behavior(GO:0048520) |
0.0 | 0.0 | GO:0001839 | neural plate morphogenesis(GO:0001839) |
0.0 | 0.0 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.0 | 0.1 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.0 | 0.0 | GO:0071599 | otic vesicle development(GO:0071599) otic vesicle morphogenesis(GO:0071600) |
0.0 | 0.0 | GO:0032229 | negative regulation of synaptic transmission, GABAergic(GO:0032229) |
0.0 | 0.0 | GO:2000463 | positive regulation of excitatory postsynaptic potential(GO:2000463) |
0.0 | 0.0 | GO:0033108 | mitochondrial respiratory chain complex assembly(GO:0033108) |
0.0 | 0.1 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
0.0 | 0.0 | GO:1901725 | regulation of histone deacetylase activity(GO:1901725) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 3.8 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
1.0 | 3.0 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.7 | 3.4 | GO:0097433 | dense body(GO:0097433) |
0.7 | 2.0 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.6 | 3.2 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.6 | 1.9 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.6 | 2.4 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.5 | 1.5 | GO:0016939 | kinesin II complex(GO:0016939) |
0.5 | 2.5 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.5 | 1.5 | GO:0097413 | Lewy body(GO:0097413) |
0.5 | 2.3 | GO:0005579 | membrane attack complex(GO:0005579) |
0.5 | 2.7 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.4 | 1.3 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.4 | 1.7 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.4 | 1.7 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.4 | 2.8 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.4 | 4.4 | GO:0070852 | cell body fiber(GO:0070852) |
0.4 | 1.2 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.4 | 1.5 | GO:0045293 | mRNA editing complex(GO:0045293) |
0.4 | 1.1 | GO:1990635 | proximal dendrite(GO:1990635) |
0.4 | 1.5 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.4 | 1.4 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.3 | 0.3 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
0.3 | 2.3 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.3 | 1.0 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) |
0.3 | 1.0 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.3 | 1.3 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.3 | 1.2 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.3 | 2.8 | GO:0071439 | clathrin complex(GO:0071439) |
0.3 | 0.8 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.3 | 0.8 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.3 | 1.1 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.3 | 0.3 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.3 | 0.8 | GO:0005827 | polar microtubule(GO:0005827) |
0.3 | 1.6 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.3 | 3.2 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.3 | 0.5 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.2 | 1.5 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.2 | 0.7 | GO:0097441 | basilar dendrite(GO:0097441) |
0.2 | 4.0 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.2 | 0.7 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.2 | 0.9 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.2 | 1.5 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.2 | 1.6 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.2 | 0.6 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.2 | 0.8 | GO:0033269 | internode region of axon(GO:0033269) |
0.2 | 0.6 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.2 | 3.1 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.2 | 0.7 | GO:0070876 | SOSS complex(GO:0070876) |
0.2 | 1.7 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.2 | 0.5 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.2 | 0.9 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.2 | 2.0 | GO:0005916 | fascia adherens(GO:0005916) |
0.2 | 3.4 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.2 | 0.2 | GO:0055087 | Ski complex(GO:0055087) |
0.2 | 1.4 | GO:0045179 | apical cortex(GO:0045179) |
0.2 | 1.2 | GO:0031305 | integral component of mitochondrial inner membrane(GO:0031305) |
0.2 | 0.5 | GO:0071942 | XPC complex(GO:0071942) |
0.2 | 1.3 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
0.2 | 0.8 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.2 | 0.5 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.2 | 1.2 | GO:0005688 | U6 snRNP(GO:0005688) |
0.2 | 1.2 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.2 | 1.8 | GO:0031512 | motile primary cilium(GO:0031512) |
0.2 | 0.6 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.2 | 0.5 | GO:0071817 | MMXD complex(GO:0071817) |
0.2 | 1.1 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.2 | 1.4 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.2 | 0.5 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.1 | 0.3 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.1 | 0.4 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.1 | 0.6 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.1 | 0.4 | GO:0044308 | axonal spine(GO:0044308) |
0.1 | 1.4 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.1 | 0.7 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.1 | 3.3 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.1 | 0.8 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.1 | 0.5 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.1 | 2.2 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.1 | 2.2 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.1 | 1.1 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.1 | 0.4 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.1 | 7.6 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 1.8 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.1 | 0.1 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.1 | 0.5 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.1 | 0.8 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.1 | 0.4 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.1 | 1.4 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.1 | 0.6 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.1 | 0.3 | GO:0000322 | storage vacuole(GO:0000322) |
0.1 | 0.1 | GO:0042827 | platelet dense granule(GO:0042827) |
0.1 | 0.1 | GO:0046930 | pore complex(GO:0046930) |
0.1 | 2.0 | GO:0044215 | other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.1 | 1.0 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.1 | 0.5 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.1 | 3.0 | GO:0044295 | axonal growth cone(GO:0044295) |
0.1 | 4.8 | GO:0045271 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.1 | 0.9 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.1 | 1.1 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.1 | 0.7 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.1 | 5.2 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.1 | 5.5 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.1 | 0.7 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.1 | 1.3 | GO:0042555 | MCM complex(GO:0042555) |
0.1 | 0.6 | GO:0051286 | cell tip(GO:0051286) |
0.1 | 0.9 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.1 | 1.4 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.1 | 0.3 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
0.1 | 1.6 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.1 | 1.5 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.1 | 0.4 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.1 | 1.2 | GO:0005839 | proteasome core complex(GO:0005839) |
0.1 | 1.5 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.1 | 0.9 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.1 | 0.9 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.1 | 0.7 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.1 | 0.2 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.1 | 0.4 | GO:0089701 | U2AF(GO:0089701) |
0.1 | 0.6 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.1 | 0.4 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.1 | 0.4 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.1 | 0.5 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.1 | 0.7 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.1 | 0.5 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.1 | 1.1 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.1 | 0.3 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.1 | 0.1 | GO:0097427 | microtubule bundle(GO:0097427) |
0.1 | 0.4 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.1 | 1.0 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.1 | 1.5 | GO:0043034 | costamere(GO:0043034) |
0.1 | 0.4 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.1 | 4.1 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.1 | 3.6 | GO:0045171 | intercellular bridge(GO:0045171) |
0.1 | 1.1 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.1 | 0.4 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.1 | 0.8 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.1 | 1.0 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.1 | 0.3 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.1 | 0.4 | GO:0071986 | Ragulator complex(GO:0071986) |
0.1 | 1.0 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
0.1 | 0.6 | GO:0016460 | myosin II complex(GO:0016460) |
0.1 | 0.6 | GO:0030662 | coated vesicle membrane(GO:0030662) |
0.1 | 0.2 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.1 | 0.5 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.1 | 0.3 | GO:1990696 | USH2 complex(GO:1990696) |
0.1 | 0.1 | GO:0005652 | nuclear lamina(GO:0005652) |
0.1 | 1.0 | GO:0098533 | ATPase dependent transmembrane transport complex(GO:0098533) |
0.1 | 0.8 | GO:0031528 | microvillus membrane(GO:0031528) |
0.1 | 0.3 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.1 | 0.3 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.1 | 2.1 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.1 | 0.3 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.1 | 0.4 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.1 | 0.7 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.1 | 0.3 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.1 | 0.5 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.1 | 0.5 | GO:0031143 | pseudopodium(GO:0031143) |
0.1 | 0.1 | GO:1990923 | PET complex(GO:1990923) |
0.1 | 0.9 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.1 | 0.5 | GO:0031931 | TORC1 complex(GO:0031931) |
0.1 | 0.6 | GO:0033177 | proton-transporting two-sector ATPase complex, proton-transporting domain(GO:0033177) |
0.1 | 2.8 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.1 | 0.5 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
0.1 | 0.1 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.1 | 0.3 | GO:0071458 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) |
0.1 | 0.2 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.1 | 1.3 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.1 | 0.1 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.1 | 0.3 | GO:0001652 | granular component(GO:0001652) |
0.1 | 0.1 | GO:0097452 | GAIT complex(GO:0097452) |
0.1 | 0.3 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.1 | 0.3 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.1 | 0.2 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.1 | 0.6 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.1 | 0.8 | GO:0097440 | apical dendrite(GO:0097440) |
0.1 | 0.5 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.1 | 0.2 | GO:0070069 | cytochrome complex(GO:0070069) |
0.1 | 0.2 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.1 | 0.2 | GO:0030870 | Mre11 complex(GO:0030870) |
0.1 | 0.2 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
0.1 | 0.2 | GO:0005746 | mitochondrial respiratory chain(GO:0005746) |
0.1 | 0.1 | GO:0032838 | cell projection cytoplasm(GO:0032838) |
0.1 | 1.2 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.1 | 1.0 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.1 | 1.5 | GO:0000922 | spindle pole(GO:0000922) |
0.1 | 0.3 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.1 | 0.4 | GO:0030914 | STAGA complex(GO:0030914) |
0.1 | 0.2 | GO:0019908 | nuclear cyclin-dependent protein kinase holoenzyme complex(GO:0019908) |
0.1 | 0.3 | GO:0090543 | Flemming body(GO:0090543) |
0.1 | 0.1 | GO:0000836 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.1 | 0.6 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.1 | 0.2 | GO:0038037 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
0.1 | 0.9 | GO:0000145 | exocyst(GO:0000145) |
0.1 | 0.6 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.1 | 0.1 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
0.1 | 1.4 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.1 | 0.4 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.1 | 0.8 | GO:0045120 | pronucleus(GO:0045120) |
0.1 | 0.4 | GO:0000782 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.1 | 2.8 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.1 | 2.5 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.1 | 0.3 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.1 | 0.1 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.1 | 0.9 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.1 | 0.9 | GO:0032982 | myosin filament(GO:0032982) |
0.1 | 0.3 | GO:0070695 | FHF complex(GO:0070695) |
0.1 | 0.8 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.1 | 0.8 | GO:0014704 | intercalated disc(GO:0014704) |
0.1 | 1.7 | GO:0098800 | inner mitochondrial membrane protein complex(GO:0098800) |
0.1 | 3.6 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.1 | 0.3 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 0.2 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.1 | 1.9 | GO:0043198 | dendritic shaft(GO:0043198) |
0.1 | 2.2 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
0.1 | 0.7 | GO:0051233 | spindle midzone(GO:0051233) |
0.0 | 1.5 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.0 | 0.2 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.0 | 0.3 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.0 | 3.8 | GO:0016607 | nuclear speck(GO:0016607) |
0.0 | 0.4 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.0 | 8.2 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
0.0 | 0.2 | GO:0032433 | filopodium tip(GO:0032433) |
0.0 | 0.1 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.0 | 3.0 | GO:0005814 | centriole(GO:0005814) |
0.0 | 54.4 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.0 | 0.2 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.0 | 1.1 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.0 | 0.1 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.0 | 0.1 | GO:0042175 | nuclear outer membrane-endoplasmic reticulum membrane network(GO:0042175) |
0.0 | 0.3 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.0 | 0.2 | GO:0071437 | invadopodium(GO:0071437) |
0.0 | 0.0 | GO:0000346 | transcription export complex(GO:0000346) |
0.0 | 0.3 | GO:0010369 | chromocenter(GO:0010369) |
0.0 | 0.1 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.0 | 0.1 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.0 | 0.1 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.0 | 0.4 | GO:0042588 | zymogen granule(GO:0042588) |
0.0 | 0.2 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.0 | 0.0 | GO:0000812 | Swr1 complex(GO:0000812) |
0.0 | 0.1 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.0 | 0.2 | GO:0030478 | actin cap(GO:0030478) |
0.0 | 0.2 | GO:0005638 | lamin filament(GO:0005638) |
0.0 | 0.6 | GO:0005614 | interstitial matrix(GO:0005614) |
0.0 | 0.5 | GO:0035267 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.0 | 0.1 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.0 | 0.0 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.0 | 0.4 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.0 | 0.2 | GO:0033263 | CORVET complex(GO:0033263) |
0.0 | 4.6 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.0 | 3.1 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.0 | 12.4 | GO:0044429 | mitochondrial part(GO:0044429) |
0.0 | 0.2 | GO:0016012 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
0.0 | 0.0 | GO:0008091 | spectrin(GO:0008091) |
0.0 | 2.2 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.0 | 3.4 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 1.7 | GO:0016605 | PML body(GO:0016605) |
0.0 | 0.5 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.0 | 0.1 | GO:0030689 | Noc complex(GO:0030689) |
0.0 | 0.2 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.0 | 0.9 | GO:0031519 | PcG protein complex(GO:0031519) |
0.0 | 0.0 | GO:0098984 | asymmetric synapse(GO:0032279) neuron to neuron synapse(GO:0098984) |
0.0 | 0.2 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.0 | 5.6 | GO:0005874 | microtubule(GO:0005874) |
0.0 | 1.3 | GO:0005643 | nuclear pore(GO:0005643) |
0.0 | 0.2 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.0 | 0.1 | GO:0005955 | calcineurin complex(GO:0005955) |
0.0 | 1.8 | GO:0000776 | kinetochore(GO:0000776) |
0.0 | 0.4 | GO:0031941 | filamentous actin(GO:0031941) |
0.0 | 0.6 | GO:0000786 | nucleosome(GO:0000786) |
0.0 | 0.1 | GO:0042581 | specific granule(GO:0042581) |
0.0 | 0.1 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.0 | 0.1 | GO:0031209 | SCAR complex(GO:0031209) |
0.0 | 0.4 | GO:1990391 | DNA repair complex(GO:1990391) |
0.0 | 1.8 | GO:0099568 | cytoplasmic region(GO:0099568) |
0.0 | 1.8 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.0 | 0.1 | GO:0016272 | prefoldin complex(GO:0016272) |
0.0 | 0.1 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.0 | 0.4 | GO:0060170 | ciliary membrane(GO:0060170) |
0.0 | 0.2 | GO:0034464 | BBSome(GO:0034464) |
0.0 | 0.2 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.0 | 1.7 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 0.1 | GO:0033270 | paranode region of axon(GO:0033270) |
0.0 | 0.0 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.0 | 0.1 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.0 | 0.0 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.0 | 0.1 | GO:0000974 | Prp19 complex(GO:0000974) |
0.0 | 0.6 | GO:0005902 | microvillus(GO:0005902) |
0.0 | 0.7 | GO:0030173 | integral component of Golgi membrane(GO:0030173) intrinsic component of Golgi membrane(GO:0031228) |
0.0 | 0.4 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.0 | 0.8 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.0 | 0.0 | GO:0097422 | tubular endosome(GO:0097422) |
0.0 | 0.2 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.0 | 0.0 | GO:0043293 | apoptosome(GO:0043293) |
0.0 | 0.0 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.0 | 0.1 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.0 | 0.0 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
0.0 | 0.0 | GO:1904949 | ATPase complex(GO:1904949) |
0.0 | 0.1 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.0 | 0.1 | GO:0030904 | retromer complex(GO:0030904) |
0.0 | 0.1 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.0 | 0.7 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.0 | 0.4 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.0 | 0.3 | GO:0034707 | chloride channel complex(GO:0034707) |
0.0 | 12.1 | GO:0005739 | mitochondrion(GO:0005739) |
0.0 | 0.1 | GO:0097228 | sperm principal piece(GO:0097228) |
0.0 | 0.4 | GO:0042641 | actomyosin(GO:0042641) |
0.0 | 0.0 | GO:0032437 | cuticular plate(GO:0032437) |
0.0 | 0.1 | GO:0000796 | condensin complex(GO:0000796) |
0.0 | 0.0 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.0 | 0.1 | GO:0043196 | varicosity(GO:0043196) |
0.0 | 0.0 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.0 | 0.1 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.0 | 1.1 | GO:0030016 | myofibril(GO:0030016) |
0.0 | 0.4 | GO:0036064 | ciliary basal body(GO:0036064) |
0.0 | 0.2 | GO:0044298 | cell body membrane(GO:0044298) |
0.0 | 0.2 | GO:0016235 | aggresome(GO:0016235) |
0.0 | 0.1 | GO:0000798 | nuclear cohesin complex(GO:0000798) |
0.0 | 0.1 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.0 | 0.0 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.0 | 0.0 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.0 | 0.1 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.0 | 0.9 | GO:0072562 | blood microparticle(GO:0072562) |
0.0 | 0.1 | GO:0033391 | chromatoid body(GO:0033391) |
0.0 | 0.0 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.0 | 0.1 | GO:0097225 | sperm midpiece(GO:0097225) |
0.0 | 0.0 | GO:0016234 | inclusion body(GO:0016234) |
0.0 | 0.0 | GO:0038201 | TORC2 complex(GO:0031932) TOR complex(GO:0038201) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.1 | 6.2 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
1.4 | 4.1 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
1.4 | 12.2 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
1.3 | 3.9 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
1.2 | 5.0 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
1.2 | 3.7 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.9 | 1.8 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.8 | 2.5 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.8 | 1.6 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.8 | 1.6 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.8 | 3.8 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
0.7 | 2.2 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.7 | 2.9 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.7 | 2.9 | GO:0071614 | linoleic acid epoxygenase activity(GO:0071614) |
0.7 | 2.1 | GO:0070538 | oleic acid binding(GO:0070538) |
0.7 | 2.0 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.6 | 1.7 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.5 | 2.7 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.5 | 0.5 | GO:0016414 | O-octanoyltransferase activity(GO:0016414) |
0.5 | 1.5 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.5 | 1.5 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.5 | 3.5 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.5 | 2.0 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.5 | 1.5 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.5 | 3.4 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.5 | 1.4 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
0.5 | 1.4 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.4 | 1.3 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.4 | 2.4 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.4 | 1.6 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.4 | 1.2 | GO:0055100 | adiponectin binding(GO:0055100) |
0.4 | 12.2 | GO:0043906 | prenylcysteine methylesterase activity(GO:0010296) 1-oxa-2-oxocycloheptane lactonase activity(GO:0018731) sulfolactone hydrolase activity(GO:0018732) butyrolactone hydrolase activity(GO:0018734) endosulfan lactone lactonase activity(GO:0034892) L-ascorbate 6-phosphate lactonase activity(GO:0035460) Ser-tRNA(Thr) hydrolase activity(GO:0043905) Ala-tRNA(Pro) hydrolase activity(GO:0043906) Cys-tRNA(Pro) hydrolase activity(GO:0043907) Ser(Gly)-tRNA(Ala) hydrolase activity(GO:0043908) all-trans-retinyl-palmitate hydrolase, all-trans-retinol forming activity(GO:0047376) mannosyl-oligosaccharide 1,6-alpha-mannosidase activity(GO:0052767) mannosyl-oligosaccharide 1,3-alpha-mannosidase activity(GO:0052768) methyl indole-3-acetate esterase activity(GO:0080030) methyl salicylate esterase activity(GO:0080031) methyl jasmonate esterase activity(GO:0080032) |
0.4 | 2.1 | GO:0043426 | MRF binding(GO:0043426) |
0.4 | 1.1 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.3 | 0.3 | GO:0016662 | oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor(GO:0016662) |
0.3 | 2.1 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.3 | 1.0 | GO:0005119 | smoothened binding(GO:0005119) |
0.3 | 1.7 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.3 | 1.4 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.3 | 1.0 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.3 | 7.5 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.3 | 0.7 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.3 | 1.0 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.3 | 1.6 | GO:0070728 | leucine binding(GO:0070728) |
0.3 | 1.9 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.3 | 0.6 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.3 | 0.9 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.3 | 1.9 | GO:0002054 | nucleobase binding(GO:0002054) |
0.3 | 4.3 | GO:0070402 | NADPH binding(GO:0070402) |
0.3 | 1.2 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.3 | 0.6 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) |
0.3 | 0.9 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.3 | 1.5 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.3 | 1.7 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.3 | 3.2 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.3 | 0.8 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.3 | 1.1 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.3 | 1.1 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.3 | 0.8 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.3 | 0.8 | GO:0008142 | oxysterol binding(GO:0008142) |
0.3 | 1.4 | GO:0004331 | fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.3 | 0.8 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.3 | 0.5 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.3 | 2.1 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.3 | 1.3 | GO:0046790 | virion binding(GO:0046790) |
0.3 | 0.5 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.3 | 3.0 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.3 | 0.8 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.2 | 0.7 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.2 | 0.7 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.2 | 0.5 | GO:0034875 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
0.2 | 3.5 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.2 | 1.2 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.2 | 0.7 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.2 | 0.7 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.2 | 0.7 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
0.2 | 3.3 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.2 | 1.1 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.2 | 0.2 | GO:0030792 | methylarsonite methyltransferase activity(GO:0030792) |
0.2 | 0.7 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.2 | 2.2 | GO:0015254 | glycerol transmembrane transporter activity(GO:0015168) glycerol channel activity(GO:0015254) |
0.2 | 5.2 | GO:0030552 | cAMP binding(GO:0030552) |
0.2 | 1.1 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.2 | 0.4 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
0.2 | 1.5 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.2 | 0.8 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.2 | 0.8 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.2 | 4.4 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.2 | 0.2 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.2 | 0.6 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.2 | 0.8 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.2 | 1.0 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.2 | 0.6 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.2 | 1.4 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.2 | 2.6 | GO:0015643 | toxic substance binding(GO:0015643) |
0.2 | 1.4 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.2 | 0.6 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.2 | 2.0 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.2 | 2.1 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.2 | 0.8 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.2 | 0.6 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.2 | 0.6 | GO:0043398 | HLH domain binding(GO:0043398) |
0.2 | 1.3 | GO:0016679 | oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) |
0.2 | 1.2 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.2 | 0.7 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.2 | 0.5 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.2 | 4.5 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.2 | 0.5 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.2 | 1.9 | GO:0034946 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
0.2 | 1.0 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.2 | 0.5 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.2 | 1.8 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.2 | 0.3 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.2 | 0.8 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.2 | 0.7 | GO:0097001 | ceramide binding(GO:0097001) |
0.2 | 1.1 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.2 | 0.8 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.2 | 0.5 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.2 | 0.2 | GO:0016420 | S-malonyltransferase activity(GO:0016419) malonyltransferase activity(GO:0016420) |
0.2 | 1.1 | GO:0003680 | AT DNA binding(GO:0003680) |
0.2 | 0.3 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.2 | 1.3 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.2 | 0.8 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.2 | 3.1 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.2 | 2.7 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.2 | 0.3 | GO:0036137 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.2 | 0.3 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.2 | 0.5 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
0.2 | 1.4 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.2 | 0.5 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.2 | 3.2 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.2 | 0.5 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.2 | 0.9 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.1 | 0.4 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.1 | 4.6 | GO:0016749 | N-succinyltransferase activity(GO:0016749) |
0.1 | 0.9 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.1 | 0.4 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.1 | 0.1 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.1 | 1.9 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.1 | 0.1 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.1 | 1.0 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.1 | 1.3 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.1 | 0.7 | GO:0000828 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.1 | 1.3 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.1 | 1.9 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.1 | 0.4 | GO:0034874 | fluorene oxygenase activity(GO:0018585) mono-butyltin dioxygenase activity(GO:0018586) tri-n-butyltin dioxygenase activity(GO:0018588) di-n-butyltin dioxygenase activity(GO:0018589) methylsilanetriol hydroxylase activity(GO:0018590) methyl tertiary butyl ether 3-monooxygenase activity(GO:0018591) 4-nitrocatechol 4-monooxygenase activity(GO:0018592) 4-chlorophenoxyacetate monooxygenase activity(GO:0018593) tert-butanol 2-monooxygenase activity(GO:0018594) alpha-pinene monooxygenase activity(GO:0018595) dimethylsilanediol hydroxylase activity(GO:0018596) ammonia monooxygenase activity(GO:0018597) hydroxymethylsilanetriol oxidase activity(GO:0018598) 2-hydroxyisobutyrate 3-monooxygenase activity(GO:0018599) alpha-pinene dehydrogenase activity(GO:0018600) bisphenol A hydroxylase B activity(GO:0034559) 2,2-bis(4-hydroxyphenyl)-1-propanol hydroxylase activity(GO:0034562) 9-fluorenone-3,4-dioxygenase activity(GO:0034786) anthracene 9,10-dioxygenase activity(GO:0034816) 2-(methylthio)benzothiazole monooxygenase activity(GO:0034857) 2-hydroxybenzothiazole monooxygenase activity(GO:0034858) benzothiazole monooxygenase activity(GO:0034859) 2,6-dihydroxybenzothiazole monooxygenase activity(GO:0034862) pinacolone 5-monooxygenase activity(GO:0034870) thioacetamide S-oxygenase activity(GO:0034873) thioacetamide S-oxide S-oxygenase activity(GO:0034874) endosulfan monooxygenase I activity(GO:0034888) N-nitrodimethylamine hydroxylase activity(GO:0034893) 4-(1-ethyl-1,4-dimethyl-pentyl)phenol monoxygenase activity(GO:0034897) endosulfan ether monooxygenase activity(GO:0034903) pyrene 4,5-monooxygenase activity(GO:0034925) pyrene 1,2-monooxygenase activity(GO:0034927) 1-hydroxypyrene 6,7-monooxygenase activity(GO:0034928) 1-hydroxypyrene 7,8-monooxygenase activity(GO:0034929) phenylboronic acid monooxygenase activity(GO:0034950) spheroidene monooxygenase activity(GO:0043823) |
0.1 | 0.6 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.1 | 2.0 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.1 | 0.4 | GO:0035671 | enone reductase activity(GO:0035671) |
0.1 | 1.8 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.1 | 0.7 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.1 | 0.6 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.1 | 0.4 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.1 | 0.8 | GO:0045545 | syndecan binding(GO:0045545) |
0.1 | 0.8 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.1 | 2.8 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 0.4 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.1 | 0.5 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.1 | 0.5 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.1 | 0.4 | GO:0032190 | acrosin binding(GO:0032190) |
0.1 | 0.4 | GO:0004096 | catalase activity(GO:0004096) |
0.1 | 4.1 | GO:0042805 | actinin binding(GO:0042805) |
0.1 | 0.3 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.1 | 0.4 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.1 | 0.3 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.1 | 1.1 | GO:0016208 | AMP binding(GO:0016208) |
0.1 | 0.8 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.1 | 1.6 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.1 | 0.6 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
0.1 | 0.8 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.1 | 0.6 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.1 | 1.2 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.1 | 0.5 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.1 | 0.5 | GO:0005290 | L-histidine transmembrane transporter activity(GO:0005290) |
0.1 | 1.1 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.1 | 0.5 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.1 | 0.4 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.1 | 3.0 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.1 | 0.2 | GO:0016653 | oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor(GO:0016653) |
0.1 | 0.4 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.1 | 0.4 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.1 | 1.1 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.1 | 0.6 | GO:0015180 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
0.1 | 2.5 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.1 | 0.4 | GO:0032551 | UTP binding(GO:0002134) pyrimidine ribonucleoside binding(GO:0032551) |
0.1 | 0.7 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.1 | 2.6 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 0.6 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.1 | 0.8 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.1 | 0.1 | GO:0033677 | DNA/RNA helicase activity(GO:0033677) |
0.1 | 0.7 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.1 | 0.3 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.1 | 1.0 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.1 | 0.8 | GO:0102338 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.1 | 1.0 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.1 | 0.2 | GO:0051425 | PTB domain binding(GO:0051425) |
0.1 | 0.4 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.1 | 0.1 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.1 | 1.7 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.1 | 0.5 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.1 | 1.6 | GO:0004120 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
0.1 | 0.7 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.1 | 0.7 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.1 | 0.5 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.1 | 0.4 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.1 | 2.6 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.1 | 2.8 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.1 | 0.2 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.1 | 0.4 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.1 | 0.5 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.1 | 0.3 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.1 | 0.1 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.1 | 1.1 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.1 | 0.9 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.1 | 1.6 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.1 | 0.2 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.1 | 1.0 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.1 | 2.6 | GO:0070330 | aromatase activity(GO:0070330) |
0.1 | 0.2 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.1 | 0.2 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.1 | 1.9 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.1 | 0.3 | GO:0015288 | porin activity(GO:0015288) |
0.1 | 0.5 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.1 | 0.6 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.1 | 0.1 | GO:0051723 | protein methylesterase activity(GO:0051723) |
0.1 | 0.7 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.1 | 0.5 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.1 | 1.3 | GO:0044769 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) |
0.1 | 0.5 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.1 | 0.9 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.1 | 0.3 | GO:0016015 | morphogen activity(GO:0016015) |
0.1 | 0.7 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
0.1 | 0.7 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.1 | 0.3 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.1 | 0.5 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.1 | 0.3 | GO:0016303 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) |
0.1 | 0.2 | GO:0016289 | CoA hydrolase activity(GO:0016289) |
0.1 | 0.7 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
0.1 | 0.5 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.1 | 0.3 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.1 | 0.4 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.1 | 0.5 | GO:0004556 | alpha-amylase activity(GO:0004556) |
0.1 | 0.4 | GO:0001642 | group III metabotropic glutamate receptor activity(GO:0001642) |
0.1 | 0.5 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.1 | 0.2 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.1 | 4.3 | GO:0035064 | methylated histone binding(GO:0035064) |
0.1 | 1.4 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.1 | 1.1 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.1 | 0.4 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.1 | 2.6 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.1 | 1.3 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.1 | 0.3 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.1 | 0.3 | GO:0036033 | mediator complex binding(GO:0036033) |
0.1 | 1.3 | GO:0071949 | FAD binding(GO:0071949) |
0.1 | 1.0 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.1 | 0.3 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.1 | 1.3 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.1 | 0.3 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.1 | 0.4 | GO:0005499 | vitamin D binding(GO:0005499) |
0.1 | 0.7 | GO:0070513 | death domain binding(GO:0070513) |
0.1 | 0.2 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.1 | 0.3 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.1 | 2.9 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.1 | 0.2 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.1 | 0.3 | GO:0038100 | nodal binding(GO:0038100) |
0.1 | 1.1 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.1 | 0.2 | GO:2001070 | starch binding(GO:2001070) |
0.1 | 0.3 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.1 | 0.2 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.1 | 1.0 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) |
0.1 | 0.5 | GO:0050733 | RS domain binding(GO:0050733) |
0.1 | 0.3 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.1 | 0.6 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
0.1 | 0.2 | GO:0097016 | L27 domain binding(GO:0097016) |
0.1 | 0.5 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.1 | 0.3 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.1 | 0.1 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.1 | 0.4 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.1 | 0.3 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.1 | 2.0 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
0.1 | 1.0 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.1 | 0.6 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.1 | 0.2 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.1 | 0.2 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.1 | 0.2 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.1 | 0.1 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.1 | 0.3 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.1 | 0.4 | GO:0033691 | sialic acid binding(GO:0033691) |
0.1 | 0.9 | GO:0001848 | complement binding(GO:0001848) |
0.1 | 0.4 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.1 | 0.4 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.1 | 0.2 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.1 | 1.4 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.1 | 0.9 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.1 | 0.1 | GO:0042281 | dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity(GO:0042281) |
0.1 | 0.1 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) alcohol transmembrane transporter activity(GO:0015665) |
0.1 | 2.1 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.1 | 0.2 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.1 | 2.9 | GO:0000049 | tRNA binding(GO:0000049) |
0.1 | 0.1 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
0.1 | 0.5 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.1 | 0.1 | GO:0003916 | DNA topoisomerase activity(GO:0003916) DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.1 | 1.5 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.1 | 0.7 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.1 | 2.0 | GO:0052770 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
0.1 | 0.3 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.1 | 0.5 | GO:0034784 | pivalyl-CoA mutase activity(GO:0034784) o-hydroxylaminobenzoate mutase activity(GO:0034951) lupeol synthase activity(GO:0042299) beta-amyrin synthase activity(GO:0042300) baruol synthase activity(GO:0080011) |
0.1 | 0.3 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.1 | 0.5 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.1 | 0.6 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.1 | 0.7 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.1 | 0.3 | GO:0070888 | E-box binding(GO:0070888) |
0.1 | 0.2 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.1 | 0.4 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.1 | 0.1 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.1 | 0.7 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.1 | 0.2 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.1 | 0.6 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.1 | 0.4 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.1 | 1.0 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.1 | 0.3 | GO:0031996 | thioesterase binding(GO:0031996) |
0.1 | 0.2 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.1 | 0.1 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.1 | 0.5 | GO:0016668 | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor(GO:0016668) |
0.1 | 1.1 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.1 | 0.1 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.1 | 0.1 | GO:0015250 | water channel activity(GO:0015250) |
0.1 | 0.4 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 0.1 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.1 | 0.2 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.1 | 0.1 | GO:0001016 | RNA polymerase III regulatory region DNA binding(GO:0001016) |
0.1 | 0.1 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.1 | 0.3 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.1 | 0.1 | GO:0043199 | sulfate binding(GO:0043199) |
0.1 | 0.8 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.1 | 1.0 | GO:0045502 | dynein binding(GO:0045502) |
0.1 | 0.3 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.1 | 0.2 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.1 | 1.1 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.1 | 0.2 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
0.1 | 0.2 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.1 | 0.7 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.1 | 1.3 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.1 | 1.3 | GO:0030332 | cyclin binding(GO:0030332) |
0.1 | 0.4 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.1 | 0.4 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.1 | 0.2 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.1 | 0.1 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.1 | 0.2 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.1 | 0.1 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.1 | 0.1 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
0.1 | 0.7 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
0.1 | 1.7 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.1 | 0.2 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.1 | 0.2 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.1 | 0.2 | GO:0071253 | connexin binding(GO:0071253) |
0.1 | 1.1 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.1 | 0.2 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.1 | 0.8 | GO:0031489 | myosin V binding(GO:0031489) |
0.1 | 0.1 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.1 | 0.4 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.1 | 0.2 | GO:0035197 | siRNA binding(GO:0035197) |
0.1 | 0.4 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.1 | 0.2 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.1 | 0.2 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.1 | 0.2 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.1 | 0.1 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.1 | 0.4 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.1 | 1.2 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.1 | 1.0 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 0.9 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.1 | 0.2 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.1 | 0.1 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.1 | 0.8 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.1 | 0.5 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.1 | 0.2 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.1 | 0.4 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.1 | 0.3 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.1 | 0.5 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.1 | 0.3 | GO:1990459 | transferrin receptor binding(GO:1990459) |
0.1 | 0.1 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.1 | 0.5 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.1 | 1.8 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.1 | 0.2 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.1 | 1.1 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 0.3 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.1 | 1.4 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.1 | 0.2 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.0 | 0.7 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.0 | 0.3 | GO:0032813 | tumor necrosis factor receptor superfamily binding(GO:0032813) |
0.0 | 0.5 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.0 | 0.2 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.0 | 0.3 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.0 | 0.1 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.0 | 0.2 | GO:1990405 | protein antigen binding(GO:1990405) |
0.0 | 0.2 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.0 | 0.6 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.0 | 0.5 | GO:0044548 | S100 protein binding(GO:0044548) |
0.0 | 6.3 | GO:0008017 | microtubule binding(GO:0008017) |
0.0 | 0.1 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.0 | 0.0 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.0 | 0.9 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.0 | 0.1 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.0 | 0.0 | GO:0016415 | octanoyltransferase activity(GO:0016415) |
0.0 | 0.2 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.0 | 0.5 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.0 | 0.1 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.0 | 1.3 | GO:0019894 | kinesin binding(GO:0019894) |
0.0 | 0.5 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.0 | 0.4 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.0 | 0.0 | GO:0015927 | trehalase activity(GO:0015927) |
0.0 | 0.1 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.0 | 0.0 | GO:0030619 | U1 snRNA binding(GO:0030619) |
0.0 | 0.4 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.0 | 0.2 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.0 | 0.1 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.0 | 0.0 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.0 | 0.2 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.0 | 0.3 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.0 | 0.8 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.0 | 0.5 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.0 | 0.1 | GO:0030551 | cyclic nucleotide binding(GO:0030551) |
0.0 | 0.1 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.0 | 0.4 | GO:0097506 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.0 | 0.1 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
0.0 | 0.1 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.0 | 1.0 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.0 | 1.0 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.0 | 1.4 | GO:0016763 | transferase activity, transferring pentosyl groups(GO:0016763) |
0.0 | 0.8 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.0 | 0.3 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.0 | 1.2 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.0 | 0.1 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.0 | 0.6 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.0 | 0.2 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.0 | 6.0 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
0.0 | 0.4 | GO:0050661 | NADP binding(GO:0050661) |
0.0 | 0.1 | GO:0004359 | glutaminase activity(GO:0004359) |
0.0 | 0.1 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.0 | 0.9 | GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) |
0.0 | 0.1 | GO:0019862 | IgA binding(GO:0019862) |
0.0 | 0.1 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.0 | 0.4 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.0 | 0.2 | GO:0030572 | cardiolipin synthase activity(GO:0008808) phosphatidyltransferase activity(GO:0030572) |
0.0 | 0.7 | GO:0008080 | N-acetyltransferase activity(GO:0008080) |
0.0 | 0.1 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.0 | 0.2 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.0 | 0.1 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.0 | 0.2 | GO:0030507 | spectrin binding(GO:0030507) |
0.0 | 0.0 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.0 | 2.0 | GO:0008565 | protein transporter activity(GO:0008565) |
0.0 | 4.2 | GO:0004386 | helicase activity(GO:0004386) |
0.0 | 0.0 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.0 | 0.3 | GO:0000150 | recombinase activity(GO:0000150) |
0.0 | 0.1 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.0 | 0.1 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.0 | 0.1 | GO:0070052 | collagen V binding(GO:0070052) |
0.0 | 0.5 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.0 | 0.4 | GO:0016918 | retinal binding(GO:0016918) |
0.0 | 0.4 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.0 | 1.0 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.0 | 0.0 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.0 | 0.2 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.0 | 0.3 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.0 | 0.2 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.0 | 0.3 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.0 | 0.7 | GO:0015485 | cholesterol binding(GO:0015485) |
0.0 | 0.2 | GO:0048495 | Roundabout binding(GO:0048495) |
0.0 | 0.0 | GO:0036222 | XTP diphosphatase activity(GO:0036222) |
0.0 | 0.7 | GO:0008392 | arachidonic acid epoxygenase activity(GO:0008392) |
0.0 | 0.1 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.0 | 0.1 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
0.0 | 0.1 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.0 | 0.1 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.0 | 0.1 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.0 | 9.2 | GO:0019001 | guanyl nucleotide binding(GO:0019001) |
0.0 | 0.0 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.0 | 0.2 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.0 | 0.5 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.0 | 1.4 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.0 | 0.4 | GO:0016860 | intramolecular oxidoreductase activity(GO:0016860) |
0.0 | 0.1 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.0 | 0.1 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
0.0 | 0.3 | GO:0060590 | ATPase regulator activity(GO:0060590) |
0.0 | 0.0 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.0 | 0.1 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
0.0 | 2.6 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.0 | 0.1 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.0 | 0.6 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.0 | 3.5 | GO:0008083 | growth factor activity(GO:0008083) |
0.0 | 0.1 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.0 | 0.2 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.0 | 0.1 | GO:0052796 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.0 | 0.2 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.0 | 0.1 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
0.0 | 0.5 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.0 | 0.3 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.0 | 0.0 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.0 | 0.1 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.0 | 0.4 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.0 | 0.1 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.0 | 0.1 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.0 | 0.1 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.0 | 0.1 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.0 | 0.5 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.0 | 0.8 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.0 | 0.2 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.0 | 0.5 | GO:0005537 | mannose binding(GO:0005537) |
0.0 | 0.1 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.0 | 0.4 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.0 | 0.2 | GO:0031386 | protein tag(GO:0031386) |
0.0 | 0.1 | GO:0043495 | protein anchor(GO:0043495) |
0.0 | 0.1 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.0 | 0.3 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.0 | 0.1 | GO:0030274 | LIM domain binding(GO:0030274) |
0.0 | 0.1 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.0 | 0.1 | GO:0016896 | 3'-5'-exoribonuclease activity(GO:0000175) exoribonuclease activity, producing 5'-phosphomonoesters(GO:0016896) |
0.0 | 0.1 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.0 | 0.1 | GO:0051380 | norepinephrine binding(GO:0051380) |
0.0 | 0.1 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.0 | 0.8 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.0 | 0.1 | GO:0051373 | FATZ binding(GO:0051373) |
0.0 | 0.4 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
0.0 | 0.0 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.0 | 3.4 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.0 | 0.0 | GO:0019187 | beta-1,4-mannosyltransferase activity(GO:0019187) |
0.0 | 0.1 | GO:0051870 | methotrexate binding(GO:0051870) |
0.0 | 0.1 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.0 | 0.1 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.0 | 0.1 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.0 | 0.2 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
0.0 | 0.4 | GO:0015295 | solute:proton symporter activity(GO:0015295) |
0.0 | 1.6 | GO:0016427 | tRNA (cytosine) methyltransferase activity(GO:0016427) tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
0.0 | 2.1 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.0 | 0.3 | GO:0001968 | fibronectin binding(GO:0001968) |
0.0 | 0.2 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.0 | 0.1 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.0 | 0.1 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.0 | 0.0 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.0 | 0.1 | GO:0052742 | phosphatidylinositol kinase activity(GO:0052742) |
0.0 | 0.2 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.0 | 0.3 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.0 | 1.7 | GO:0101005 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.0 | 0.0 | GO:0004954 | prostanoid receptor activity(GO:0004954) |
0.0 | 2.8 | GO:0003729 | mRNA binding(GO:0003729) |
0.0 | 0.0 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
0.0 | 0.4 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.0 | 0.1 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.0 | 0.0 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.0 | 0.1 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.0 | 0.1 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.0 | 0.1 | GO:0008200 | ion channel inhibitor activity(GO:0008200) |
0.0 | 0.1 | GO:0051429 | corticotropin-releasing hormone receptor binding(GO:0051429) |
0.0 | 0.3 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.0 | 0.4 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.0 | 0.0 | GO:0008199 | ferric iron binding(GO:0008199) |
0.0 | 0.0 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.0 | 0.0 | GO:0019808 | polyamine binding(GO:0019808) |
0.0 | 0.1 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.0 | 1.1 | GO:0044325 | ion channel binding(GO:0044325) |
0.0 | 0.1 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.0 | 0.1 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.0 | 0.1 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.0 | 0.2 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.0 | 0.0 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.0 | 0.1 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 0.0 | GO:0019767 | IgE receptor activity(GO:0019767) |
0.0 | 0.4 | GO:0015179 | L-amino acid transmembrane transporter activity(GO:0015179) |
0.0 | 4.3 | GO:0003779 | actin binding(GO:0003779) |
0.0 | 3.4 | GO:0046982 | protein heterodimerization activity(GO:0046982) |
0.0 | 0.7 | GO:0000149 | SNARE binding(GO:0000149) |
0.0 | 0.3 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.0 | 0.2 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.0 | 0.0 | GO:0031782 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.0 | 0.1 | GO:0008494 | translation activator activity(GO:0008494) |
0.0 | 0.1 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.0 | 0.1 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.0 | 0.0 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.0 | 0.3 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.0 | 0.2 | GO:0099589 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.0 | 0.5 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.0 | 0.1 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.0 | 0.1 | GO:0030506 | ankyrin binding(GO:0030506) |
0.0 | 0.8 | GO:0000009 | alpha-1,6-mannosyltransferase activity(GO:0000009) |
0.0 | 0.0 | GO:0048030 | disaccharide binding(GO:0048030) |
0.0 | 0.1 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.0 | 0.6 | GO:0005518 | collagen binding(GO:0005518) |
0.0 | 0.0 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
0.0 | 0.1 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.0 | 0.0 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.0 | 0.3 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.0 | 0.0 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.0 | 0.0 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.0 | 0.1 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) dopamine neurotransmitter receptor activity(GO:0004952) |
0.0 | 0.1 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.0 | 0.1 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.0 | 0.0 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.0 | 0.0 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.0 | 0.0 | GO:0017166 | vinculin binding(GO:0017166) |
0.0 | 0.2 | GO:0008061 | chitin binding(GO:0008061) |
0.0 | 0.4 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
0.0 | 0.5 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.0 | 0.0 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.0 | 0.6 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.0 | 0.1 | GO:0071813 | lipoprotein particle binding(GO:0071813) protein-lipid complex binding(GO:0071814) |
0.0 | 4.6 | GO:0000981 | RNA polymerase II transcription factor activity, sequence-specific DNA binding(GO:0000981) |
0.0 | 0.1 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.0 | 0.2 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.0 | 0.0 | GO:0008443 | phosphofructokinase activity(GO:0008443) |
0.0 | 0.0 | GO:0004673 | phosphorelay sensor kinase activity(GO:0000155) protein histidine kinase activity(GO:0004673) |
0.0 | 0.0 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.0 | 0.0 | GO:0004936 | alpha-adrenergic receptor activity(GO:0004936) |
0.0 | 0.4 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 0.0 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.0 | 0.0 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.0 | 0.0 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.0 | 0.0 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.0 | 0.0 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.0 | 0.0 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.0 | 0.0 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.0 | 0.1 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.0 | 0.1 | GO:0008430 | selenium binding(GO:0008430) |
0.0 | 0.0 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.0 | 0.0 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.0 | 0.1 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.0 | 0.0 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.0 | 0.0 | GO:0015928 | fucosidase activity(GO:0015928) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 5.1 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.3 | 1.9 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.3 | 3.8 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.2 | 8.6 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.2 | 5.8 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.2 | 6.0 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.2 | 0.6 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.2 | 2.2 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.2 | 3.6 | PID IGF1 PATHWAY | IGF1 pathway |
0.2 | 4.3 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.2 | 5.7 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.2 | 6.4 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.1 | 3.9 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 4.7 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.1 | 0.7 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.1 | 3.7 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.1 | 1.0 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.1 | 2.3 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 0.7 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.1 | 1.6 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.1 | 0.6 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.1 | 1.1 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.1 | 1.6 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.1 | 0.1 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.1 | 0.4 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.1 | 5.3 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.1 | 1.6 | PID BARD1 PATHWAY | BARD1 signaling events |
0.1 | 0.7 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.1 | 0.2 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.1 | 1.0 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.1 | 1.0 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.1 | 1.1 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.1 | 1.5 | PID AURORA A PATHWAY | Aurora A signaling |
0.1 | 1.2 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 3.2 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.1 | 1.0 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.1 | 2.1 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.1 | 0.7 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.1 | 1.3 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.1 | 1.3 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 1.0 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 0.3 | PID EPO PATHWAY | EPO signaling pathway |
0.1 | 0.8 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.1 | 0.5 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.1 | 0.4 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.1 | 0.6 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.1 | 0.4 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.1 | 0.9 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 0.7 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 0.1 | ST STAT3 PATHWAY | STAT3 Pathway |
0.1 | 0.8 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.1 | 0.2 | ST ADRENERGIC | Adrenergic Pathway |
0.1 | 1.3 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.1 | 0.1 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 1.3 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.1 | 0.2 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.1 | 1.4 | PID P53 REGULATION PATHWAY | p53 pathway |
0.1 | 1.0 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.0 | 0.2 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 0.5 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.0 | 0.4 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.0 | 0.3 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.0 | 0.4 | PID RHOA PATHWAY | RhoA signaling pathway |
0.0 | 0.7 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.0 | 0.9 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.0 | 1.0 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.0 | 0.4 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.0 | 0.3 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 0.6 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.0 | 0.6 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 1.3 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 0.7 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.0 | 0.3 | PID BCR 5PATHWAY | BCR signaling pathway |
0.0 | 0.8 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.0 | 0.1 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.0 | 0.1 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.0 | 0.5 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.0 | 0.1 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.0 | 0.4 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.0 | 0.2 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.0 | 0.4 | PID INSULIN PATHWAY | Insulin Pathway |
0.0 | 0.2 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.0 | 0.1 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.0 | 0.0 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.0 | 0.2 | PID RAS PATHWAY | Regulation of Ras family activation |
0.0 | 0.1 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.0 | 0.1 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.0 | 0.3 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 0.0 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.0 | 0.1 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.0 | 0.1 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.0 | 0.1 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.0 | 4.6 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 0.0 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.0 | 0.3 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.0 | 0.8 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.0 | 0.1 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.0 | 0.1 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 0.1 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.0 | 0.2 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.0 | 0.2 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.0 | 0.0 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.0 | 0.2 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.0 | 0.1 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 0.7 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.0 | 0.1 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 2.9 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.4 | 5.4 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.4 | 7.6 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
0.3 | 5.8 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.3 | 0.3 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.3 | 3.2 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.3 | 4.1 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.3 | 2.3 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.3 | 6.7 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.3 | 2.5 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.3 | 2.4 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.2 | 2.2 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.2 | 1.7 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.2 | 2.3 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.2 | 0.7 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
0.2 | 0.5 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.2 | 2.2 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.2 | 2.0 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.2 | 0.2 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.2 | 2.9 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.2 | 6.3 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.2 | 3.9 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.2 | 1.5 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.2 | 0.7 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.2 | 2.1 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.2 | 4.5 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.2 | 1.7 | REACTOME ORC1 REMOVAL FROM CHROMATIN | Genes involved in Orc1 removal from chromatin |
0.2 | 2.5 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.2 | 2.7 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.2 | 1.9 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.2 | 1.5 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.1 | 1.7 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.1 | 1.8 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.1 | 1.8 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.1 | 3.6 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.1 | 0.8 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
0.1 | 0.7 | REACTOME BILE ACID AND BILE SALT METABOLISM | Genes involved in Bile acid and bile salt metabolism |
0.1 | 4.6 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.1 | 1.4 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.1 | 0.5 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.1 | 4.1 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.1 | 1.5 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.1 | 1.2 | REACTOME CDT1 ASSOCIATION WITH THE CDC6 ORC ORIGIN COMPLEX | Genes involved in CDT1 association with the CDC6:ORC:origin complex |
0.1 | 4.5 | REACTOME SIGNALING BY ERBB4 | Genes involved in Signaling by ERBB4 |
0.1 | 3.4 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.1 | 1.4 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.1 | 1.0 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.1 | 1.4 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.1 | 1.6 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.1 | 0.2 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.1 | 1.9 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.1 | 0.8 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.1 | 0.8 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.1 | 4.8 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.1 | 4.9 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.1 | 0.1 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
0.1 | 1.6 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.1 | 0.7 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.1 | 1.0 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.1 | 1.8 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.1 | 2.2 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.1 | 0.9 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.1 | 1.0 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.1 | 0.2 | REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21 | Genes involved in SCF(Skp2)-mediated degradation of p27/p21 |
0.1 | 1.6 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.1 | 1.2 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.1 | 0.2 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.1 | 0.1 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.1 | 0.9 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.1 | 0.3 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.1 | 2.0 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.1 | 0.7 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.1 | 1.1 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.1 | 0.9 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.1 | 9.8 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.1 | 0.8 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.1 | 0.8 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.1 | 0.1 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.1 | 4.5 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.1 | 0.1 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.1 | 1.2 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.1 | 1.1 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.1 | 1.5 | REACTOME KINESINS | Genes involved in Kinesins |
0.1 | 0.5 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.1 | 0.7 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.1 | 0.7 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.1 | 1.0 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.1 | 0.1 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
0.1 | 0.8 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.1 | 1.5 | REACTOME BIOLOGICAL OXIDATIONS | Genes involved in Biological oxidations |
0.1 | 1.5 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.1 | 1.8 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.1 | 1.6 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.1 | 0.9 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
0.1 | 1.1 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.1 | 0.2 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.1 | 1.1 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.1 | 0.1 | REACTOME P75NTR SIGNALS VIA NFKB | Genes involved in p75NTR signals via NF-kB |
0.1 | 1.6 | REACTOME NCAM SIGNALING FOR NEURITE OUT GROWTH | Genes involved in NCAM signaling for neurite out-growth |
0.1 | 1.8 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.1 | 0.3 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.1 | 0.1 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.1 | 0.7 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.1 | 1.0 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.1 | 1.9 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
0.1 | 0.3 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.1 | 0.5 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.1 | 0.7 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.1 | 1.7 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.1 | 0.2 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.1 | 0.3 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.0 | 0.8 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.0 | 0.7 | REACTOME RNA POL II PRE TRANSCRIPTION EVENTS | Genes involved in RNA Polymerase II Pre-transcription Events |
0.0 | 0.8 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.0 | 0.3 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.0 | 2.6 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.0 | 0.8 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.0 | 0.5 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.0 | 0.3 | REACTOME SIGNALING BY FGFR1 MUTANTS | Genes involved in Signaling by FGFR1 mutants |
0.0 | 0.0 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.0 | 0.2 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.0 | 0.5 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.0 | 1.8 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.0 | 0.4 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.0 | 0.2 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.0 | 0.5 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.0 | 0.4 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.0 | 0.3 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.0 | 2.2 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.4 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 1.0 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.0 | 0.8 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.0 | 0.3 | REACTOME OPSINS | Genes involved in Opsins |
0.0 | 0.5 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.0 | 0.3 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.0 | 0.2 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.0 | 0.7 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.0 | 0.5 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.0 | 0.3 | REACTOME DEFENSINS | Genes involved in Defensins |
0.0 | 0.3 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.0 | 0.8 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.0 | 0.5 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.0 | 0.1 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.0 | 0.8 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.0 | 0.2 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.0 | 0.4 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.0 | 1.3 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 0.3 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.0 | 0.1 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.0 | 0.4 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.0 | 0.0 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.0 | 0.5 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.0 | 0.0 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.0 | 0.4 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.0 | 0.0 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.0 | 0.1 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.0 | 0.4 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.0 | 0.4 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.0 | 0.1 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.0 | 2.1 | REACTOME 3 UTR MEDIATED TRANSLATIONAL REGULATION | Genes involved in 3' -UTR-mediated translational regulation |
0.0 | 0.9 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.0 | 0.1 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.0 | 0.1 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.0 | 0.2 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.0 | 0.1 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
0.0 | 0.1 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.0 | 0.4 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.0 | 1.8 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 0.3 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
0.0 | 0.2 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.0 | 0.1 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.0 | 0.2 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.0 | 2.2 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.0 | 0.3 | REACTOME MITOTIC G1 G1 S PHASES | Genes involved in Mitotic G1-G1/S phases |
0.0 | 0.1 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.0 | 0.3 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 0.0 | REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | Genes involved in Transport of Mature Transcript to Cytoplasm |
0.0 | 0.3 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.0 | 0.1 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
0.0 | 0.2 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.0 | 1.0 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.0 | 0.0 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.0 | 0.1 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.0 | 0.2 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.0 | 0.0 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.0 | 0.1 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.0 | 0.0 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.0 | 0.0 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.0 | 0.0 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |